Neurological diseases, wide definition

NEURODIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints G6_NEUINFL G6_NEUATR G6_XTRAPYR NEURODEGOTH G6_DEMYEL G6_EPIPAROX G6_NERPLEX G6_POLYNEU G6_MYONEU G6_CPETAL G6_OTHNEU ST19_INTRACRATRAUMA I9_CEREBVASC	247861
6. Filter based on genotype QC (FinnGen only)	239826

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	NEURODIS
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_NEUINFL\|G6_NEUATR\|G6_XTRAPYR\|NEURODEGOTH\|G6_DEMYEL\|G6_EPIPAROX\|G6_NERPLEX\|G6_POLYNEU\|G6_MYONEU\|G6_CPETAL\|G6_OTHNEU\|ST19_INTRACRATRAUMA\|I9_CEREBVASC
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Neurological diseases, wide definition based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	239826	129454	110372
Unadjusted period prevalence (%)	48.06	45.92	50.57
Median age at first event (years)	53.97	51.28	57.12

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
22357: Matched controls
112237

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.6

323.0

2528

5292

M54.6

ICD-10 Finland

Pain in thoracic spine

3.9

322.7

1256

1683

L88

ICPC

Rheumatoid/seropositive arthritis

36.2

322.0

355

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

321.7

3538

8690

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

319.6

15423

61871

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

317.2

1512

2354

OAB50, ,

SPAT

7.8

316.9

633

418

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

708.0

316.5

413

M01AE01

ATC

ibuprofen; systemic, rectal

2.1

316.4

18963

81592

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

315.3

3416

8330

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.3

315.1

1583

2554

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

12.4

312.3

477

197

A10AA02, ,

ATC

238.8

312.3

421

R52.2

ICD-10 Finland

Other chronic pain

8.7

307.8

571

337

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

307.7

2060

3831

A10AB01

ATC

insulin (human); parenteral

140.7

307.7

547

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

31.7

307.7

997

165

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

8.6

307.7

1502

931

M01AX05

ATC

glucosamine; oral

4.1

307.7

1564

2006

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

20.2

307.7

1174

307

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

26.1

307.7

1174

238

N02BF02

ATC

pregabalin; oral

9.0

307.7

1003

581

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

7.1

307.7

1650

1251

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

9.3

307.7

819

455

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

307.7

5603

13632

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

256.8

307.7

694

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

307.7

5659

14428

C03CA01

ATC

furosemide; systemic

3.0

307.7

2979

5438

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

20.5

307.7

668

168

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

83.1

307.7

951

N03AX14

ATC

levetiracetam; systemic

42.4

307.7

617

R5140

NOMESCO Finland

Monitoring the use of the aid

22.5

307.7

2120

519

215

Kela drug reimbursment

Diabetes, non-insulin-treated

409.2

307.7

3092

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

307.7

3200

6489

M79.0

ICD-10 Finland

Rheumatism, unspecified

49.5

307.7

388

N05BA01

ATC

diazepam; systemic, rectal

3.4

307.7

2160

3386

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

4.0

307.7

2922

4108

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

307.7

461

E66.01

ICD-10 Finland

Obesity due to excess calories

5.0

307.7

1941

2115

SPAT1310

SPAT

Counselling related to known health issue

2.0

307.7

5923

17255

SPAT1263

SPAT

Sampling

2.0

307.7

8115

24915

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

16.2

307.7

1278

419

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

307.7

7328

15176

X59

ICD-10 Finland

Exposure to unspecified factor

2.8

307.7

3579

7070

M02AA07

ATC

piroxicam; topical

2.2

307.7

4652

12070

R4110

NOMESCO Finland

Physiotherapy

2.7

307.7

4408

9249

R20.2

ICD-10 Finland

Paraesthesia of skin

4.7

307.7

1427

1598

N03AX11

ATC

topiramate; oral

19.5

307.7

674

179

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

307.7

9587

32165

SPAT1262

SPAT

Handing over of treatment supplies

6.4

307.7

2317

1985

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.2

307.7

1457

1852

G43.3

ICD-10 Finland

Complicated migraine

34.1

307.7

551

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

307.7

2974

6323

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

57.1

307.7

457

R42

ICD-10 Finland

Dizziness and giddiness

3.2

307.7

3642

6363

A10BJ02

ATC

liraglutide; parenteral

61.9

307.7

352

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.5

307.7

4631

7760

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

307.7

11803

43412

N06AB04

ATC

citalopram; systemic

2.7

307.7

3629

7404

T90

ICPC

Diabetes non-insulin dependent

22.3

307.7

2657

675

A02BC05

ATC

esomeprazole; systemic

2.4

307.7

6679

16864

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.1

307.7

1938

2050

M79.7

ICD-10 Finland

Fibromyalgia

17.2

307.7

593

178

R4120

NOMESCO Finland

Occupational therapy

7.0

307.7

1114

838

M79.1

ICD-10 Finland

Myalgia

3.4

307.7

2808

4569

A28

ICPC

Limited function/disability NOS

3.8

307.7

1679

2354

C08CA01

ATC

amlodipine; oral

2.4

307.7

4257

10102

N06AA09

ATC

amitriptyline; systemic

7.1

307.7

1215

900

E66.00

ICD-10 Finland

Metabolic syndrome

7.1

307.7

766

559

X58

ICD-10 Finland

Exposure to other specified factors

2.7

307.7

2796

5743

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.3

307.7

8108

16713

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

186.3

307.7

365

N03AX12

ATC

[U] gabapentin; oral

15.7

307.7

3054

1118

R01AD09

ATC

mometasone; nasal

1.9

307.7

9089

30143

L13

ICPC

Hip symptom/complaint

3.1

307.7

2105

3595

103

Kela drug reimbursment

Diabetes, insulin-treated

256.8

307.7

3351

P01BA02

ATC

hydroxychloroquine; oral

18.5

307.7

909

257

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

9.3

307.7

630

348

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.3

307.7

5194

13282

N02AJ06

ATC

codeine and paracetamol; systemic

3.4

307.7

8391

16844

N03AE01

ATC

clonazepam; systemic

7.3

307.7

934

670

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

12.4

307.7

2473

1112

R06.0

ICD-10 Finland

Dyspnoea

3.0

307.7

4185

8091

T89

ICPC

Diabetes insulin dependent

80.8

307.7

626

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

307.7

10934

38461

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

307.7

7493

23984

J01DB01

ATC

cefalexin; oral

2.4

307.7

17278

65734

N89

ICPC

Migraine

5.1

307.7

1250

1295

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

15.1

307.7

1338

470

G51.0

ICD-10 Finland

Bell palsy

46.6

307.7

499

A10AE04

ATC

insulin glargine; parenteral

68.1

307.7

1256

M54.5

ICD-10 Finland

Low back pain

3.7

307.7

7175

12608

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

307.7

6051

18037

N02BE01

ATC

paracetamol; systemic, rectal

3.5

307.7

18243

62970

L12

ICPC

Hand/finger symptom/complaint

2.5

307.7

3055

6742

WX002

NOMESCO Finland

Sedation and analgesia

2.6

307.7

2612

5413

SPAT1216

SPAT

Assessment of functional ability

3.3

307.7

1801

2926

TAB00

NOMESCO Finland

Lumbar puncture

12.7

307.7

1095

453

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.0

307.7

5150

10245

E11

ICD-10 Finland

Type 2 diabetes mellitus

21.2

307.7

1604

408

M01AH05

ATC

etoricoxib; oral

2.7

307.7

11257

31032

A10AE06

ATC

insulin degludec; parenteral

823.9

307.7

474

A10BJ06

ATC

semaglutide; parenteral

+∞

307.7

638

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.1

307.7

2575

4493

N04BC05

ATC

pramipexole; oral

7.4

307.7

968

682

A01

ICPC

Pain general/multiple sites

4.1

307.7

1404

1821

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

153.9

307.7

480

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.4

307.7

1494

1784

P06

ICPC

Sleep disturbance

3.1

307.7

2585

4477

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

307.7

2300

4561

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

307.7

3174

6226

ACC51

NOMESCO Finland

Release of median nerve

470.5

307.7

1569

SPAT1229

SPAT

Assessment of need for aid

6.3

307.7

794

650

A07EC01

ATC

sulfasalazine; oral, rectal

11.5

307.7

966

438

M01AC06

ATC

meloxicam; systemic, rectal

2.5

307.7

5132

11820

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.1

307.7

1412

1820

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.2

307.7

1103

1101

M17.1

ICD-10 Finland

Other primary gonarthrosis

13.1

307.7

2045

858

R53

ICD-10 Finland

Malaise and fatigue

2.6

307.7

4727

10438

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

8.6

307.7

2196

1403

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

52.1

307.7

1691

176

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.2

307.7

1384

1735

L01

ICPC

Neck symptom/complaint

2.6

307.7

2899

6117

M20.1

ICD-10 Finland

Hallux valgus (acquired)

7.1

307.7

748

543

NA1AD

NOMESCO Finland

Cervical spine CT examination

7.6

307.7

807

548

A02BC03

ATC

lansoprazole; oral

2.5

307.7

4006

8953

C07AB07

ATC

bisoprolol; oral

2.7

307.7

6614

15035

N03AF02

ATC

oxcarbazepine; oral

58.7

307.7

834

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

11.9

307.7

1265

563

A10AE05

ATC

insulin detemir; parenteral

165.6

307.7

703

G43.9

ICD-10 Finland

Migraine, unspecified

11.2

307.7

2236

1107

R56.8

ICD-10 Finland

Other and unspecified convulsions

7.7

307.7

1295

884

B01AB05

ATC

enoxaparin; parenteral

2.3

307.7

4129

9940

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

751

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

5.9

307.7

1029

917

C10AA05

ATC

atorvastatin; oral

2.6

307.7

4774

10713

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

307.7

1403

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.2

307.7

1143

1161

H02AB06

ATC

prednisolone; systemic

2.7

307.7

8380

20496

S06.0

ICD-10 Finland

Concussion

22.8

307.7

3633

948

M01AX17

ATC

nimesulide; oral

2.7

307.7

2720

5543

M70.6

ICD-10 Finland

Trochanteric bursitis

4.6

307.7

1465

1678

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

6.9

307.7

1300

997

A10AB05

ATC

insulin aspart; parenteral

54.8

307.7

1041

100

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

307.7

3739

9268

M19.0

ICD-10 Finland

Primary arthrosis of other joints

13.7

307.7

1065

409

SPAT1301

SPAT

No procedures

2.1

307.7

5529

15413

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

158.7

307.7

373

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

154.4

307.7

452

A10BB12

ATC

glimepiride; oral

111.9

307.7

437

N03AX09

ATC

lamotrigine; oral

5.5

307.7

1281

1217

M03BC51

ATC

orphenadrine, combinations; systemic

2.4

307.7

4614

10974

G47.3

ICD-10 Finland

Sleep apnoea

25.6

307.7

5492

1412

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.1

307.7

4409

8327

G35

ICD-10 Finland

Multiple sclerosis

374.3

307.7

439

E66.8

ICD-10 Finland

Other obesity

6.2

307.7

1086

918

J01FF01

ATC

clindamycin; systemic

2.3

307.7

4489

11101

C07AA05

ATC

propranolol; systemic

2.5

307.7

4277

9532

C09CA06

ATC

candesartan; oral

2.7

307.7

3763

7889

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

5.5

307.7

1126

1065

NF1AA

NOMESCO Finland

Hip X-ray examination

10.4

307.7

803

402

N06AX11

ATC

mirtazapine; oral

2.7

307.7

6488

14693

J01AA02

ATC

doxycycline; systemic

2.1

307.7

14042

50432

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.5

307.7

1193

1142

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

414.7

307.7

1248

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

44.2

307.7

2634

338

A02BC02

ATC

pantoprazole; systemic

3.0

307.7

12445

33305

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

307.7

3869

9655

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.3

307.7

2078

3408

Z3231

NOMESCO Finland

Registered nurse

2.3

307.7

4698

11596

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

59.5

307.7

812

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

3.6

307.7

3956

6308

N01

ICPC

Headache

2.5

307.7

3192

7034

M54.2

ICD-10 Finland

Cervicalgia

5.3

307.7

1386

1395

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

37.4

307.7

539

G40.9

ICD-10 Finland

Epilepsy, unspecified

277.6

307.7

800

M03BX02

ATC

tizanidine; oral

2.6

307.7

12300

35486

Z01.8

ICD-10 Finland

Other specified special examinations

3.3

307.7

4209

7465

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

307.7

5043

12312

A10AB04

ATC

insulin lispro; parenteral

96.0

307.7

468

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.0

307.7

2184

2368

M16.1

ICD-10 Finland

Other primary coxarthrosis

20.8

307.7

876

220

J01DA01

ATC

[U] cefalexin

1.8

307.7

11564

41956

M01AE02

ATC

naproxen; oral, rectal

2.3

307.7

11818

36563

M54.3

ICD-10 Finland

Sciatica

7.6

307.7

798

541

L08

ICPC

Shoulder symptom/complaint

2.6

307.7

3218

6747

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

12.7

307.7

637

259

ZXA00

NOMESCO Finland

Right side

2.9

307.7

3502

6737

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

307.7

4133

8652

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

307.7

8453

26572

WX780

NOMESCO Finland

Remote monitoring CPAP

1555.4

307.7

908

R51.80

ICD-10 Finland

Headache

5.1

307.7

4234

4893

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

307.7

7796

19350

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

125.4

307.7

584

Z3226

NOMESCO Finland

Physiotherapist

3.2

307.7

2915

4960

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

9.2

307.7

2271

1368

A10BK01

ATC

dapagliflozin; oral

49.5

307.7

679

WX320

NOMESCO Finland

Spinalanesthesy

2.5

307.7

2997

6560

N06AB10

ATC

escitalopram; oral

2.3

307.7

4690

11713

ZXA05

NOMESCO Finland

Left side

2.7

307.7

3171

6560

A10BA02

ATC

metformin; oral

23.5

307.7

3489

875

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

56.8

307.7

912

M48.0

ICD-10 Finland

Spinal stenosis

47.2

307.7

1152

129

XA800

NOMESCO Finland

Neuropsychological investigation

10.8

307.7

967

469

AA1AD

NOMESCO Finland

CT of head and brain

8.5

307.7

4935

3613

N03AX16

ATC

[U] pregabalin

7.6

307.7

4001

3116

M01AB05

ATC

diclofenac; systemic, rectal

2.3

307.7

12081

37893

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

307.7

3446

7219

N03AG01

ATC

valproic acid; systemic, rectal

7.2

307.7

1385

1026

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.0

307.7

3635

5231

N02AX02

ATC

tramadol; systemic, rectal

4.3

307.7

7475

11794

L15

ICPC

Knee symptom/complaint

2.7

307.7

3720

7829

P01AB01

ATC

metronidazole; oral, rectal

1.9

307.7

7000

21294

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

23.1

307.7

652

146

N03AF01

ATC

carbamazepine; oral, rectal

10.0

307.7

767

398

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

307.7

10825

37768

C10AA01

ATC

simvastatin; oral

2.4

307.7

4078

9684

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

307.7

2242

4350

I10

ICD-10 Finland

Essential (primary) hypertension

2.3

307.7

7478

20084

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

21.3

307.7

2332

609

M03BC01

ATC

orphenadrine (citrate); systemic

3.2

307.7

4295

7691

L86

ICPC

Back syndrome with radiating pain

6.1

307.7

859

734

M01AH01

ATC

celecoxib; oral

3.5

307.7

2091

3177

N02AA05

ATC

oxycodone; systemic

3.0

307.7

1910

3379

H04AA01

ATC

glucagon; nasal, parenteral

179.9

307.7

422

WX723

NOMESCO Finland

CPAP therapy

558.9

307.7

857

M79.6

ICD-10 Finland

Pain in limb

3.8

307.7

7999

14303

G56.0

ICD-10 Finland

Carpal tunnel syndrome

18.3

307.7

2974

932

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

307.7

556

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

4.9

307.7

2242

2480

NE1AA

NOMESCO Finland

Pelvis X-ray examination

7.9

307.7

719

469

N06AX16

ATC

venlafaxine; oral

3.5

307.7

3165

5097

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

31.8

307.7

646

105

L04AX03

ATC

methotrexate; systemic

9.2

307.7

1250

715

N02BF01

ATC

gabapentin; oral

13.4

307.7

1380

547

G56.2

ICD-10 Finland

Lesion of ulnar nerve

17.6

307.7

654

192

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1008.4

307.7

796

M54.1

ICD-10 Finland

Radiculopathy

12.9

307.7

542

216

L17

ICPC

Foot/toe symptom/complaint

2.5

307.7

4842

11373

S18

ICPC

Laceration/cut

2.3

307.7

7533

20104

G43

ICD-10 Finland

Migraine

3.5

307.7

1585

2375

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

307.7

2137

3987

A10BK03

ATC

empagliflozin; oral

95.1

307.7

1013

R06.5

ICD-10 Finland

Mouth breathing

4.2

307.7

1692

2126

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

9.4

307.7

2568

1532

G44.2

ICD-10 Finland

Tension-type headache

6.3

307.7

3531

3265

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.6

307.7

3073

6432

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.8

307.7

3308

6486

SPAT1153

SPAT

Removal of sutures

2.4

307.7

4544

10851

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

307.7

428

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

116.3

307.7

869

A10AC01

ATC

insulin (human); parenteral

16.8

307.7

1054

330

N05BA04

ATC

oxazepam; oral

2.6

307.7

4869

10880

M54.4

ICD-10 Finland

Lumbago with sciatica

5.8

307.7

3130

3047

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

9.3

307.7

2052

1202

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

123.9

307.7

412

N06AX21

ATC

duloxetine; oral

6.6

307.7

2380

1991

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

12.6

307.7

1534

654

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

606.2

307.7

473

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

10.9

307.7

657

311

B01AC04

ATC

clopidogrel; oral

4.4

307.7

1560

1894

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

99.9

307.7

391

M13.9

ICD-10 Finland

Arthritis, unspecified

10.3

307.7

953

485

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.2

307.7

2938

5089

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

98.2

307.7

572

G54.0

ICD-10 Finland

Brachial plexus disorders

17.4

307.7

634

188

A10BH01

ATC

sitagliptin; oral

653.6

307.7

876

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

19.1

307.7

516

139

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

307.7

2638

4817

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1278.3

307.7

508

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

23.4

307.7

546

120

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

11216

35093

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

307.7

15149

58003

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

307.7

4314

10990

M25.5

ICD-10 Finland

Pain in joint

4.3

307.7

5977

8863

L28

ICPC

Limited function/disability (L)

4.9

307.7

2178

2413

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

689

A02BC01

ATC

omeprazole; systemic

2.4

307.7

4238

10009

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

93.2

307.7

960

N05AH04

ATC

quetiapine; oral

3.2

307.7

4207

7537

WX722

NOMESCO Finland

PEEP

12.4

307.7

660

274

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

11.3

307.7

693

316

N05CF01

ATC

zopiclone; oral

2.4

307.7

4907

11655

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

35.7

307.7

724

105

L03

ICPC

Low back symptom/complaint

2.8

307.7

5320

11127

R11

ICD-10 Finland

Nausea and vomiting

3.1

306.9

1643

2762

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

95.7

306.2

301

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

26.8

305.2

358

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

983.5

304.5

395

J01MA02

ATC

ciprofloxacin; systemic

1.9

303.6

5806

17538

XCK10

NOMESCO Finland

Photography of fundus of eye

4.3

303.4

1036

1244

3007

Kela drug reimbursment

Erenumab and fremanezumab

23.5

303.3

368

G43.8

ICD-10 Finland

Other migraine

13.2

302.8

450

175

XG466

NOMESCO Finland

Sleep oxymetry

14.4

302.7

433

154

UJF32

NOMESCO Finland

Coloscopy

2.2

302.2

3297

8052

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

302.1

5892

17911

M43.1

ICD-10 Finland

Spondylolisthesis

19.9

301.2

383

W19

ICD-10 Finland

Unspecified fall

3.1

301.0

1639

2784

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.8

300.3

1954

3694

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.2

299.8

1533

2500

N80.1

ICD-10 Finland

Endometriosis of ovary

37.1

298.8

328

Z71.8

ICD-10 Finland

Other specified counselling

1.9

297.8

6068

18698

C10AX09

ATC

ezetimibe; oral

3.1

297.4

1591

2672

M03BX01

ATC

baclofen; systemic

25.6

296.8

352

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

6.9

296.6

647

482

C07AB02

ATC

metoprolol; systemic

2.6

296.5

2250

4624

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

4.3

296.4

1013

1217

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

295.5

3004

7107

SPAT1254

SPAT

Administration of medicine

2.4

295.4

2634

5866

L01BA01

ATC

methotrexate; systemic

23.6

294.8

357

M23.8

ICD-10 Finland

Other internal derangements of knee

8.8

294.7

541

314

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

42.3

294.2

316

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.6

291.5

2239

4629

R02

ICPC

Shortness of breath/dyspnoea

2.8

291.1

1949

3742

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

13.3

290.0

429

165

ZXE00

NOMESCO Finland

One hour or less

1.8

289.5

6700

21460

C10AA07

ATC

rosuvastatin; oral

2.1

288.7

3667

9521

205

Kela drug reimbursment

Chronic hypertension

2.5

288.1

2447

5320

J01FA06

ATC

roxithromycin; oral

1.8

286.9

6373

20141

J01CA04

ATC

amoxicillin; systemic

1.9

286.6

17727

75226

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

286.4

366

M01AH02

ATC

rofecoxib; oral

3.6

282.7

1245

1829

N80.9

ICD-10 Finland

Endometriosis, unspecified

20.4

281.9

356

C09AA05

ATC

ramipril; oral

2.4

281.3

2536

5670

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

23.2

280.1

341

A10AA01, ,

ATC

271.5

278.1

373

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

13.6

277.9

407

153

SPAT1260

SPAT

Consultation of another employee

2.3

276.3

2885

6893

XA402

NOMESCO Finland

ENMG

22.0

276.1

341

M22.4

ICD-10 Finland

Chondromalacia patellae

10.3

275.5

461

228

A04

ICPC

Weakness/tiredness general

2.3

272.7

2817

6696

T82

ICPC

Obesity

5.1

272.3

771

775

H03BB01

ATC

carbimazole; oral

18.6

272.3

354

M65.3

ICD-10 Finland

Trigger finger

7.5

271.2

555

379

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.3

270.8

1316

2071

WX290

NOMESCO Finland

Other blockage of nerve

1.7

270.4

10518

38862

M47.82

ICD-10 Finland

Other spondylosis, cervical region

15.9

270.0

371

119

N02CC03

ATC

zolmitriptan; nasal, oral

3.6

269.5

1170

1700

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

60.8

268.6

275

R05

ICPC

Cough

2.0

268.4

4284

12087

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

12.2

266.2

409

171

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

266.0

340

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

265.7

2775

6623

M47.9

ICD-10 Finland

Spondylosis, unspecified

33.6

265.7

297

109

Kela drug reimbursment

Multiple sclerosis

+∞

265.2

339

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.1

263.4

958

1212

ZXD05

NOMESCO Finland

Urgent procedure

1.8

262.9

5406

16593

H03AA01

ATC

levothyroxine sodium; systemic

2.1

262.2

3256

8350

R60.0

ICD-10 Finland

Localized oedema

3.1

261.6

1394

2330

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.7

261.2

819

909

L90

ICPC

Osteoarthrosis of knee

8.5

260.9

489

293

N06AB03

ATC

fluoxetine; oral

2.5

260.9

2105

4451

J01FA10

ATC

azithromycin; systemic

1.7

259.9

12111

46736

N05CF02

ATC

zolpidem; oral

2.2

259.2

2746

6590

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

39.7

259.0

281

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1671.0

258.1

333

E66

ICD-10 Finland

Obesity

3.9

257.8

1006

1347

G30.1

ICD-10 Finland

Alzheimer disease with late onset

11.0

256.9

415

192

N02CC07

ATC

frovatriptan; oral

4.0

256.1

967

1261

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1655.5

255.7

330

R52.9

ICD-10 Finland

Pain, unspecified

3.0

254.9

1499

2663

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

97.6

254.6

250

F51.0

ICD-10 Finland

Nonorganic insomnia

2.1

254.1

3262

8468

R06AE07

ATC

cetirizine; oral

1.7

252.6

8639

30660

R01AD12

ATC

fluticasone furoate; nasal

1.7

252.6

6504

21331

N06AB06

ATC

sertraline; oral

2.4

252.2

2328

5248

R50.9

ICD-10 Finland

Fever, unspecified

2.2

252.0

2668

6396

85000

ICD-8 Finland

Concussion, Current or unspecified

+∞

251.9

322

A10BH05

ATC

linagliptin; oral

422.6

251.3

332

OAB93, ,

SPAT

3.1

250.5

1336

2233

N06AX12

ATC

bupropion; oral

2.7

250.1

1690

3252

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.4

249.8

2305

5194

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

5.1

249.1

710

718

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

248.7

318

SPAT1377

SPAT

Polysomnography

7.3

248.0

517

362

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.8

248.0

1002

1378

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

247.4

5632

17786

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

246.2

2330

5311

A02BA02

ATC

ranitidine; systemic

2.4

246.1

2283

5156

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

29.8

245.3

281

SFA10

NOMESCO Finland

One-surface restoration

1.6

244.6

11273

43098

K02.1

ICD-10 Finland

Caries of dentine

1.6

244.3

12572

49415

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1578.1

244.0

315

R03DC03

ATC

montelukast; oral

2.2

243.9

2877

7210

B01AF01

ATC

rivaroxaban; oral

3.6

243.4

1056

1532

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

242.8

2134

4697

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

8.5

242.6

457

276

N02CC04

ATC

rizatriptan; oral

3.3

242.6

1210

1935

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

242.1

2298

5243

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

26.0

242.0

286

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

37.4

241.8

265

SPAT1283

SPAT

Restricted health certificate

1.9

241.2

4692

14090

SPAT1240

SPAT

Therapeutic discussion

2.2

240.9

2621

6349

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

30.8

240.1

273

M54

ICD-10 Finland

Dorsalgia

2.4

240.0

2211

4974

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

23.5

240.0

291

R51

ICD-10 Finland

Headache

3.2

239.6

1225

1991

R74

ICPC

Upper respiratory infection acute

1.7

239.5

7488

25844

A46

ICD-10 Finland

Erysipelas

2.7

239.0

1667

3261

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

23.7

238.9

289

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

237.8

304

Z2445

NOMESCO Finland

Psychologist

3.6

237.1

1012

1450

L11

ICPC

Wrist symptom/complaint

2.6

237.0

1728

3461

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

237.0

3194

8430

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.4

235.9

2076

4569

R5110, ,

SPAT

5.4

235.9

638

611

R4110, ,

SPAT

3.5

235.6

1051

1555

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.6

235.5

479

324

G20

ICD-10 Finland

Parkinson disease

115.6

234.7

228

A10BD07

ATC

metformin and sitagliptin; systemic

522.3

234.4

308

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

8.5

232.7

436

261

L04AA13

ATC

[U] leflunomide

114.6

232.6

226

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

200.5

232.3

316

E66.9

ICD-10 Finland

Obesity, unspecified

5.2

232.3

653

651

J02AC01

ATC

fluconazole; systemic

1.7

232.0

6758

22834

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

231.1

6703

22617

Z2446

NOMESCO Finland

Social worker

3.0

230.1

1305

2264

P20

ICPC

Memory disturbance

3.6

230.1

1007

1469

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

10.7

229.5

377

180

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.2

228.3

642

640

M04AA01

ATC

allopurinol; systemic

3.3

228.0

1105

1732

L16

ICPC

Ankle symptom/complaint

2.4

227.9

2063

4598

M02AA10

ATC

ketoprofen; topical

2.4

227.7

1975

4314

R01AD08

ATC

fluticasone; nasal

1.8

227.6

5210

16414

SPAT1097

SPAT

Recording of ECG

2.6

227.6

1667

3345

R01AD58

ATC

fluticasone, combinations; nasal

1.8

226.4

5010

15620

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.0

226.2

1266

2178

M45

ICD-10 Finland

Ankylosing spondylitis

48.3

226.0

238

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.8

225.9

1484

2806

A10BB01

ATC

glibenclamide; oral

71.9

225.5

227

R07.3

ICD-10 Finland

Other chest pain

2.8

225.2

1431

2655

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

+∞

225.2

288

H02AB04

ATC

methylprednisolone; systemic

2.4

224.6

1916

4151

C09CA01

ATC

losartan; oral

2.1

224.1

2744

6965

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

47.9

223.8

236

N06DX01

ATC

memantine; oral

6.9

223.5

486

360

SFA20

NOMESCO Finland

Two-surface restoration

1.6

223.5

11713

45800

L02

ICPC

Back symptom/complaint

2.5

223.1

1856

3971

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

67.4

223.1

226

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.7

221.9

1561

3064

R55

ICD-10 Finland

Syncope and collapse

2.7

221.4

1488

2849

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

1428.7

221.3

286

A06AD11

ATC

lactulose; oral

2.5

220.8

1717

3552

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1423.5

220.5

285

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.2

219.9

1143

1876

N05AX08

ATC

risperidone; systemic

2.9

218.3

1333

2416

N02CC06

ATC

eletriptan; oral

4.0

218.1

822

1069

D01

ICPC

Abdominal pain/cramps general

2.2

218.0

2420

5898

M10.9

ICD-10 Finland

Gout, unspecified

5.8

216.9

548

487

WX111

NOMESCO Finland

Local infiltration anesthesia

106.9

216.2

211

N02CD03

ATC

fremanezumab; systemic

25.1

215.7

257

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

34.6

215.1

239

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

61.7

214.2

219

M35.7

ICD-10 Finland

Hypermobility syndrome

17.7

213.5

282

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

13.6

213.0

311

116

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.8

212.6

4519

13880

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.8

212.4

1405

2665

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

34.2

211.9

236

G44.0

ICD-10 Finland

Cluster headache syndrome

21.3

211.9

264

T90.5

ICD-10 Finland

Sequelae of intracranial injury

55.5

211.7

219

E10

ICD-10 Finland

Type 1 diabetes mellitus

207.9

211.4

287

ZXA10

NOMESCO Finland

Bilateral

2.1

209.3

2462

6139

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.3

208.3

2014

4618

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.3

207.7

1004

1569

L29

ICPC

Musculoskeletal sympt/complt other

2.9

207.6

1254

2257

N06AX26

ATC

vortioxetine; oral

2.5

207.1

1601

3298

H53.1

ICD-10 Finland

Subjective visual disturbances

3.1

207.1

1095

1816

B01AA03

ATC

warfarin; systemic

2.5

206.6

1729

3705

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

205.4

4105

12354

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

5.1

205.2

585

591

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

41.5

205.2

221

Z50.1

ICD-10 Finland

Other physical therapy

5.1

204.8

576

574

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.4

204.7

1743

3766

D11

ICPC

Diarrhoea

2.1

204.3

2451

6157

N02CD01

ATC

erenumab; parenteral

28.5

204.1

236

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.9

203.4

1219

2183

M77.1

ICD-10 Finland

Lateral epicondylitis

2.8

203.3

1273

2339

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

203.1

1649

3481

J01FA09

ATC

clarithromycin; systemic

1.7

203.1

5354

17478

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

202.8

3450

9850

N02CC05

ATC

almotriptan; oral

3.7

202.7

852

1205

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

174.6

201.4

276

M67.4

ICD-10 Finland

Ganglion

3.4

201.0

935

1423

ZXE20

NOMESCO Finland

More than three and less than five hours

2.4

200.6

1793

3963

WX402

NOMESCO Finland

General anaesthesia

1.9

200.6

3592

10428

G47.9

ICD-10 Finland

Sleep disorder, unspecified

5.5

200.2

527

490

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

200.1

3494

10058

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

199.8

5717

19070

N05BA09

ATC

clobazam; oral

99.3

199.8

196

OAA65, ,

SPAT

1.8

199.6

3784

11188

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.8

199.5

791

1070

D07AC01

ATC

betamethasone; topical

1.7

199.0

5727

19130

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

7.3

197.6

410

285

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.8

197.1

1260

2342

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

54.4

196.7

204

C08CA13

ATC

lercanidipine; oral

2.8

196.6

1285

2418

G04BD12

ATC

mirabegron; oral

3.0

196.6

1114

1928

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

196.3

1486

3026

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

196.2

251

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.1

196.0

713

900

SFA30

NOMESCO Finland

Three-surface restoration

1.6

195.9

6932

24404

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.7

195.4

800

1109

A03

ICPC

Fever

1.8

195.3

3870

11595

M01AG02

ATC

tolfenamic acid; oral, rectal

2.1

195.0

2377

6002

K90

ICPC

Stroke/cerebrovascular accident

191.7

194.4

265

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.7

194.3

1361

2660

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

35.1

194.1

215

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

11.1

194.0

312

143

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

193.9

8248

30342

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

19.8

193.3

246

SGA01

NOMESCO Finland

Emergency treatment

1.9

193.0

3239

9191

J01MA12

ATC

levofloxacin; systemic

2.1

192.9

2284

5700

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

43.5

192.7

206

R03BA05

ATC

fluticasone; inhalant

1.9

192.6

3272

9323

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

636.9

191.8

251

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

191.8

4431

13897

G50.0

ICD-10 Finland

Trigeminal neuralgia

16.0

190.5

261

N18

ICPC

Paralysis/weakness

38.8

190.2

207

L04AB01

ATC

etanercept; parenteral

69.4

190.1

192

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

2712

5890

2.49

321.98

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1113

1368

4.25

317.46

5.0

6.4

24.49

24.29

mmol/l

1.41

1055

1313

(1002224) Polysomnography panel

1391

2044

3.58

316.53

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

6119

18640

1.89

313.86

2.4

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4558

12529

2.04

312.29

3.6

2.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

854

833

5.31

310.95

1.9

1.3

1.18

1.15

g/l

1.58

813

786

(3019060) Gas panel - Arterial blood

1233

1688

3.82

308.04

5.9

4.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

834

802

5.38

307.78

1.9

1.3

0.23

g/l

0.12

795

751

(3002030) Lymphocytes/100 leukocytes in Blood

10347

29290

2.44

307.65

6.6

4.4

29.32

30.18

11.31

9837

27561

(3002385) Erythrocyte distribution width [Ratio]

17110

70668

1.92

307.65

16.6

9.0

14.40

14.65

0.69

16879

68833

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

998

374

13.98

307.65

1.6

1.4

3.60

3.42

mmol/l

5.01

935

352

(3016502) Oxygen saturation in Arterial blood

1887

3152

3.19

307.65

9.1

8.3

95.99

96.43

1.65

1817

3024

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5039

10134

2.93

307.65

2.1

1.6

0.98

1.32

mg/l

6.90

3645

7348

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15857

53945

2.64

307.65

4.2

2.9

14.54

14.39

pmol/l

11.43

14790

48937

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1997

2661

4.04

307.65

2.4

2.2

23.11

21.99

au/ml

0.18

154

368

(3020682) Albumin/Creatinine [Ratio] in Urine

4616

6470

4.25

307.65

4.1

2.1

11.82

10.72

mg/mmol

0.45

3115

3579

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7172

16912

2.66

307.65

1.9

1.5

97.75

96.68

pmol/l

0.96

3935

9030

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

20035

84704

2.80

307.65

10.4

5.7

28.40

25.76

u/l

41.26

19567

81376

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

986

393

13.13

307.65

1.8

1.5

4850.70

787.20

e6/l

0.56

804

296

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7083

14487

3.13

307.65

3.3

2.1

31.93

53.27

ng/l

3.49

3933

6709

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1576

1865

4.49

307.65

4.5

5.5

1.26

1.33

mmol/l

0.27

1154

1293

(3019150) Specific gravity of Urine by Refractometry

4638

12668

2.06

307.65

3.9

2.3

1.02

kg/l

3.95

645

2043

(3000850) Epithelial cells [#/volume] in Urine

4288

9384

2.60

307.65

2.7

2.0

6.48

6.74

e6/l

0.42

3882

8104

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2635

5367

2.66

307.65

2.6

1.9

23.70

24.42

1.31

2274

4702

(3015377) Calcium [Moles/volume] in Serum or Plasma

6169

16115

2.27

307.65

2.9

3.7

2.35

2.36

mmol/l

4.41

5578

14553

(3001604) Monocytes [#/volume] in Blood

10624

28212

2.70

307.65

6.5

4.5

0.56

0.55

e9/l

5.97

9384

24201

(3030467) Casts [#/volume] in Urine by Automated count

5470

13575

2.35

307.65

3.2

2.3

0.33

0.46

e6/l

3.12

4206

9292

(3019069) Monocytes/100 leukocytes in Blood

10026

27457

2.51

307.65

6.9

4.7

8.26

8.28

0.30

9507

25690

(3009508) Creatinine [Moles/volume] in Urine

5694

10013

3.49

307.65

3.6

1.9

8.30

8.54

mmol/l

1.89

4987

8929

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3544

7541

2.62

307.65

3.5

2.6

388.85

899.18

ng/l

6.11

2166

4960

(3021601) Nitrite [Presence] in Urine by Test strip

9863

30516

2.11

307.65

4.9

3.3

0.00

estimate

3.51

2110

5492

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10021

26611

2.61

307.65

5.7

6.1

10.93

12.55

umol/l

15.18

9442

25116

(40758558) Short blood count panel - Blood

5138

14435

2.02

307.65

6.8

6.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

19472

71816

3.80

307.65

14.9

7.5

3.93

3.92

mmol/l

10.83

19047

68629

(3013650) Neutrophils [#/volume] in Blood by Automated count

11830

34549

2.53

307.65

9.1

8.0

4.09

3.88

e9/l

17.00

10486

29645

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2130

3579

3.20

307.65

8.5

7.7

5.09

kpa

0.02

2044

3404

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3145

6103

2.85

307.65

1.8

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2173

3878

3.01

307.65

1.7

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2131

3576

3.20

307.65

8.5

7.7

13.03

14.25

kpa

11.93

2048

3402

(3037467) Urinalysis macro (dipstick) panel - Urine

13622

44370

2.39

307.65

4.4

2.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

2722

5536

2.67

307.65

1.8

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

5192

13388

2.23

307.65

4.5

3.5

93.37

92.43

1.80

5058

13085

(3003396) Base excess in Arterial blood by calculation

2135

3591

3.19

307.65

8.5

7.7

1.09

0.66

mmol/l

4.63

1667

2838

(3018418) pH of Serum or Plasma

5401

11717

2.73

307.65

3.9

3.2

7.40

0.21

1098

2101

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7281

19696

2.27

307.65

3.4

2.9

31.70

32.25

u/l

0.20

6918

18876

(3002032) Base excess in Venous blood by calculation

1894

3344

3.01

307.65

5.1

3.9

1.84

1.69

mmol/l

0.87

1599

2756

(3035350) Ketones [Presence] in Urine by Test strip

9902

30364

2.14

307.65

3.7

2.3

0.00

estimate

0.05

2153

5571

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

14206

53528

1.91

307.65

3.5

2.3

44.48

34.66

u/l

33.66

13522

51050

(3020630) Protein [Mass/volume] in Serum or Plasma

1386

1883

3.87

307.65

2.4

2.8

67.11

66.04

g/l

3.83

1288

1740

(3022096) Basophils/100 leukocytes in Blood

9662

26155

2.50

307.65

6.6

4.6

0.66

0.67

0.89

9123

24296

(3022217) INR in Platelet poor plasma by Coagulation assay

8330

17776

3.16

307.65

10.9

8.3

1.15

1.17

inr

1.01

2625

5430

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1127

420

14.13

307.65

1.6

1.4

461.10

411.25

mg/l

1.88

1070

397

(3021589) Normoblasts [#/volume] in Blood

9073

28146

2.04

307.65

9.7

6.4

0.00

e9/l

0.47

7455

22578

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2593

3729

3.82

307.65

2.1

2.4

370.77

394.63

nmol/l

5.63

2414

3482

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17477

69412

2.21

307.65

4.1

2.6

5.82

5.39

mmol/l

282.19

16287

64460

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

501

100

25.70

307.65

1.1

238.22

207.26

mg/l

1.30

435

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1865

2390

4.18

307.65

1.3

1.2

58.49

48.50

au/ml

0.58

184

(3037522) Nuclear Ab [Titer] in Serum

3451

4794

4.09

307.65

1.4

1.2

513.53

405.05

titre

1.86

624

657

(3012544) pH of Venous blood

1942

3475

2.98

307.65

5.1

4.0

7.37

7.36

—

(3013707) Erythrocyte sedimentation rate by Westergren method

14668

42140

3.17

307.65

4.1

2.2

9.80

8.78

mm/h

16.88

13782

38482

(3013826) Glucose [Moles/volume] in Serum or Plasma

11956

29440

3.23

307.65

5.2

3.5

6.46

5.97

mmol/l

104.67

11178

25869

(3006315) Basophils [#/volume] in Blood

10650

28247

2.70

307.65

6.5

4.5

0.04

e9/l

2.97

9395

24212

(3031040) Bacteria [#/volume] in Urine by Automated count

13048

42966

2.26

307.65

4.5

2.9

1552.29

839.98

e6/l

0.79

199

482

(40760892) CBC W Ordered Manual Differential panel - Blood

10045

26295

2.67

307.65

7.0

4.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1055

932

5.91

307.65

1.2

1.1

0.58

0.48

u/ml

0.13

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14646

43590

2.99

307.65

7.2

5.8

76.07

78.23

u/l

4.98

13934

40703

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

519

104

25.62

307.65

1.2

1.1

40.78

27.75

mg/l

4.99

426

(3020564) Creatinine [Moles/volume] in Serum or Plasma

20164

82340

3.34

307.65

14.8

7.6

73.03

72.41

umol/l

2.13

20159

82265

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2845

5930

2.61

307.65

2.5

1.8

2.42

2.44

g/l

0.54

2647

5509

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2640

4860

2.96

307.65

7.0

5.4

1.07

mmol/l

0.05

2464

4564

(3005719) IgG [Mass/volume] in Serum or Plasma

2079

2936

3.82

307.65

2.5

2.4

10.43

10.63

g/l

1.02

1911

2710

(3019198) Lymphocytes [#/volume] in Blood

10953

30000

2.63

307.65

6.5

4.4

2.02

2.00

e9/l

0.29

9868

26466

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5838

15728

2.17

307.65

1.4

1.2

1.76

2.20

u/ml

1.12

1601

4277

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

424

25.21

307.65

1.6

1.7

—

(3008898) HLA-B27 [Presence]

1105

1141

5.06

307.65

1.1

1.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3230

6548

2.73

307.65

4.2

4.1

0.82

0.83

mmol/l

4.28

3034

6247

(3007164) IgA [Mass/volume] in Serum or Plasma

5109

13453

2.18

307.65

1.5

1.3

2.19

2.11

g/l

2.35

3270

8571

(3006504) Eosinophils/100 leukocytes in Blood

9957

27283

2.50

307.65

6.6

4.5

2.83

2.90

2.07

9427

25466

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4043

8070

2.85

307.65

3.2

2.5

1219.07

945.43

ng/l

2.65

3267

6713

(3004588) Protein electrophoresis panel - Serum or Plasma

1056

1200

4.59

307.65

2.0

2.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8289

22139

2.40

307.65

2.4

1.9

72.32

73.83

nmol/l

4.47

7644

20561

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6478

14884

2.67

307.65

2.8

2.2

67.32

66.81

u/l

0.01

6033

13761

(3009261) Glucose [Presence] in Urine by Test strip

9927

30830

2.11

307.65

3.7

2.3

0.00

estimate

1.30

2021

5460

(3009343) pH of Capillary blood

1622

1911

4.52

307.65

4.5

5.5

7.41

7.42

0.83

193

173

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

494

27.54

307.65

1.1

—

(3026782) Osmolality of Urine

4018

9315

2.42

307.65

2.9

2.1

551.53

561.78

mosm/kgh2o

1.56

3529

7754

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3668

5139

4.09

307.65

1.3

1.1

7.09

1.78

u/ml

7.09

1473

2197

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

18107

66406

2.94

307.65

5.0

3.3

1.85

2.28

mu/l

3.04

17114

61525

(3013512) EKG study

4859

11637

2.40

307.65

3.3

2.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

547

141

19.94

307.65

1.1

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3127

5786

2.99

307.65

1.7

1.5

1165.67

1136.19

nmol/l

0.83

2423

4272

(3044889) 12 lead EKG panel

12577

40962

2.24

307.65

3.4

2.4

—

(3012516) Albumin [Mass/volume] in Urine

4458

6084

4.35

307.65

3.5

1.9

474.99

447.10

mg/l

0.11

3045

3336

(3013115) Eosinophils [#/volume] in Blood

10994

29591

2.70

307.65

6.8

4.8

0.19

e9/l

0.56

9836

25772

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9363

21327

3.07

307.65

7.1

5.2

1.21

1.22

mmol/l

1.94

8011

18064

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5069

12028

2.44

307.65

2.3

2.0

2.82

2.69

mg/l

2.94

4387

10210

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

987

394

13.11

307.65

1.7

1.5

28.74

12.56

e6/l

1.47

767

288

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3847

8243

2.62

307.65

1.6

1.4

44313794.67

25510497.32

pmol/l

0.87

3306

7107

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3340

5506

3.40

307.65

2.8

2.4

29.58

30.10

4.22

3222

5365

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6494

8205

5.19

307.65

2.3

1.6

256.85

199.59

u/l

1.36

6186

7666

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16246

59926

2.32

307.65

5.2

2.4

38.79

35.42

mmol/mol

303.02

15347

55897

(3042936) Bacteria identified in Isolate by Culture

2841

5797

2.67

307.65

2.1

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

5993

15146

2.35

307.65

3.3

2.3

98.21

109.45

e6/l

0.15

4661

10616

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

807

675

6.19

307.65

2.0

1.2

—

(3015736) pH of Urine

8190

24567

2.06

307.65

3.4

2.2

5.95

6.01

1.04

750

3060

(3019550) Sodium [Moles/volume] in Serum or Plasma

19439

71420

3.81

307.65

14.9

7.4

139.56

139.73

mmol/l

20.61

19055

68479

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7792

24173

1.95

307.65

3.7

2.3

—

(40761511) CBC panel - Blood by Automated count

20070

85099

2.80

307.65

13.1

6.4

—

(36304419) Bacteria [Presence] in Urine

5462

13681

2.33

307.65

3.1

2.3

—

(3044290) Cell count panel - Cerebral spinal fluid

933

367

13.27

307.65

1.8

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3913

5850

3.86

307.65

1.3

1.1

23.29

14.19

iu/ml

7.35

1134

1753

(3022313) Gas panel - Capillary blood

1206

1437

4.40

307.65

4.8

6.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

3116

6627

2.58

307.65

2.5

1.8

14.14

14.71

umol/l

2.92

2914

6225

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10012

32858

1.96

307.65

3.1

2.4

93.70

84.63

ug/l

3.47

9402

31157

(3018095) Leukocytes [#/volume] in Urine

7036

19073

2.24

307.65

3.9

2.6

55.22

89.58

e6/l

3.63

5026

11686

(3024561) Albumin [Mass/volume] in Serum or Plasma

8175

19778

2.69

307.65

4.9

4.7

36.61

36.58

g/l

0.18

7678

18360

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

17642

68047

2.43

307.65

11.6

6.6

93.10

90.81

ml/min/173m2

30.92

14675

52125

(3021960) Folate [Moles/volume] in Serum or Plasma

4151

8837

2.67

307.65

1.5

1.3

19.98

20.14

nmol/l

0.28

3694

7731

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1635

1917

4.54

307.65

4.5

5.5

5.15

5.04

kpa

4.81

1567

1817

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

19657

75520

3.54

307.65

14.1

6.9

19.86

25.04

mg/l

77.58

15957

51937

(3026493) Urate [Moles/volume] in Serum or Plasma

4708

10442

2.60

307.65

2.5

2.0

2919.09

5043.07

umol/l

3.06

4190

9567

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9264

30410

1.90

307.65

2.6

2.3

—

(3029937) Albumin [Presence] in Urine by Test strip

5452

15394

2.03

307.65

4.0

2.4

0.00

estimate

0.61

2042

5293

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8559

19069

3.03

307.65

6.6

5.0

1.21

mmol/l

1.97

7904

17348

(3023368) Bacteria identified in Blood by Culture

4904

10723

2.66

307.65

4.3

3.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2205

3940

3.01

307.65

1.8

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

10218

28756

2.44

307.65

6.4

4.3

56.28

55.43

9.42

9713

27054

(3026008) Bacteria identified in Urine by Culture

5696

14774

2.26

307.65

2.8

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1910

3369

3.02

307.65

5.1

3.9

5.89

5.81

kpa

2.09

1854

3271

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1736

3034

3.03

304.77

9.6

8.1

125.20

121.46

g/l

8.38

1692

2936

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

341

31.59

301.33

1.1

1.00

0.96

u/l

0.49

149

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3253

7942

2.24

298.02

2.7

2.2

1.00

1.15

e6/l

0.80

1812

3927

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

806

778

5.36

296.28

2.5

2.3

385.29

380.86

ug/l

0.02

737

733

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1213

1692

3.75

295.55

8.1

6.0

24.48

24.40

mmol/l

0.25

1155

1587

(3016018) Differential panel - Cerebral spinal fluid

482

229

10.78

294.38

1.8

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1503

2455

3.22

293.07

1.8

1.23

1.33

g/l

1.16

1410

2273

(3023410) Appearance of Cerebral spinal fluid

487

239

10.44

292.34

2.2

1.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

427

164

13.31

288.87

1.4

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1610

2795

3.04

285.16

4.7

3.8

4.83

4.79

kpa

0.28

1563

2708

(3000475) Leukocytes [#/volume] in Synovial fluid

387

121

16.32

284.40

1.7

1.2

12724.16

20216.51

e6/l

0.37

276

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

405

151

13.69

277.51

2.4

1.9

173.91

114.94

ug/min

0.55

265

(3020779) Urea [Moles/volume] in Serum or Plasma

1726

3243

2.81

267.05

9.4

6.0

8.00

7.35

mmol/l

3.39

1667

3126

(3009542) Hematocrit [Volume Fraction] of Blood

21071

96189

2.73

265.00

21.0

10.1

40.64

41.34

3.52

20084

90797

(3014111) Lactate [Moles/volume] in Serum or Plasma

1740

3304

2.78

264.15

7.9

7.4

1.37

1.31

mmol/l

0.93

1702

3217

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17783

76192

1.84

262.55

4.3

2.9

2.80

2.96

mmol/l

96.83

16766

71722

(3017181) Myelocytes/100 leukocytes in Blood

1716

3244

2.79

262.51

4.4

3.8

0.82

0.92

0.61

541

1048

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

360

118

15.55

259.86

1.3

1.1

1.85

mmol/l

0.00

337

109

(3007461) Platelets [#/volume] in Blood

21080

96387

2.71

259.30

20.9

10.0

259.25

254.97

e9/l

17.73

20765

92800

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17636

75531

1.82

256.65

4.1

2.8

4.64

4.86

mmol/l

160.77

16730

71561

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2230

4895

2.43

255.82

6.1

3.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

443

234

9.68

255.15

3.2

2.4

0.96

0.78

nmol/l

2.60

374

214

(3035941) MCH [Entitic mass]

21087

96588

2.69

252.93

20.8

10.0

30.06

30.02

3.19

20928

94843

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17516

74998

1.80

251.77

4.0

2.8

1.40

1.51

mmol/l

236.06

16539

70985

(3024731) MCV [Entitic volume]

21086

96619

2.68

251.36

20.8

10.0

89.90

89.66

11.58

20928

94866

(3026361) Erythrocytes [#/volume] in Blood

21088

96640

2.68

251.05

20.9

10.0

4.58

4.59

e12/l

1.90

20748

92841

(3010813) Leukocytes [#/volume] in Blood

21090

96666

2.68

250.55

20.9

10.0

6.89

6.51

e9/l

69.06

20752

92805

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16932

71829

1.76

249.85

3.7

2.6

1.34

1.16

mmol/l

145.29

15908

67748

(3021440) Promyelocytes/100 leukocytes in Blood

1636

3093

2.79

249.85

4.5

3.9

0.12

0.11

0.12

464

912

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1035

1452

3.70

249.60

1.9

2.2

38.76

41.32

u/l

2.91

952

1346

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1356

2307

3.08

247.15

2.5

1.8

6.67

10.81

ug/l

5.54

1190

2034

(3000963) Hemoglobin [Mass/volume] in Blood

21089

96747

2.66

246.91

21.0

10.1

136.93

137.21

g/l

1.98

20927

95000

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4682

13959

1.86

246.89

1.7

1.4

1.50

1.25

mmol/l

37.02

4050

12283

(3002179) Metamyelocytes/100 leukocytes in Blood

1584

2966

2.81

245.93

4.0

3.7

0.59

0.64

0.38

466

924

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1295

2149

3.15

245.43

4.3

3.7

81.87

73.18

ng/l

2.36

1159

1908

(3021788) Differential panel - Synovial fluid

307

20.82

244.74

1.5

1.1

—

(40761535) Cells panel - Urine sediment

1506

2752

2.87

243.87

3.5

2.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

378

161

11.97

243.78

1.8

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3007

7709

2.11

240.72

2.6

3.4

2.42

2.43

mmol/l

2.38

2638

6727

(3048689) Calprotectin [Mass/mass] in Stool

3288

8736

2.04

239.95

2.4

2.8

102.72

132.50

ug/g

5.05

2613

7003

(3041096) Erythrocytes [Presence] in Urine by Automated

5733

18368

1.76

238.53

3.2

2.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1532

2865

2.81

238.17

3.1

2.6

4.57

4.58

pmol/l

0.21

1379

2562

(3009445) Proteinase 3 Ab [Units/volume] in Serum

921

1229

3.88

236.79

1.5

1.3

9.62

5.87

u/ml

0.51

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3068

7979

2.08

236.47

2.9

2.2

3.22

2.88

e6/l

0.84

1637

3971

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4648

14012

1.84

235.32

2.4

1.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

432

252

8.76

234.39

1.1

20499.22

11.70

iu/ml

0.57

121

(3000991) Gas panel - Venous blood

1730

3510

2.60

231.36

9.7

8.1

—

(3025159) Blasts/100 leukocytes in Blood

1549

2965

2.74

230.84

4.5

3.9

0.29

0.50

0.29

373

791

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

685

752

4.69

220.75

1.2

1.1

35.50

7.89

u/ml

1.54

(3019225) pH of Specimen

1767

3723

2.50

219.00

3.6

2.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1871

4077

2.42

216.35

3.3

2.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

631

654

4.96

215.84

1.2

1.1

10.78

10.95

u/ml

0.01

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3646

10421

1.90

214.80

1.9

1.5

1.46

1.27

36.85

3239

9572

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

620

645

4.93

211.25

1.2

1.1

8.48

2.99

u/ml

0.53

(3004119) Hemoglobin [Mass/volume] in Venous blood

1121

1869

3.12

210.27

4.0

3.3

132.02

131.14

g/l

0.52

1093

1826

(3009466) Valproate [Moles/volume] in Serum or Plasma

550

512

5.50

208.70

5.5

6.4

374.86

411.17

umol/l

4.66

494

438

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1471

2904

2.65

206.48

9.5

8.2

24.71

24.64

mmol/l

0.31

1460

2885

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1173

2058

2.96

202.55

10.2

9.9

1.44

1.26

5.54

1166

2051

(3020891) Body temperature

779

1046

3.84

198.35

5.1

3.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

764

1014

3.88

197.41

1.6

1.5

397.39

177.41

titre

0.75

(3027945) Reticulocytes/100 erythrocytes in Blood

1862

4218

2.33

197.40

3.2

2.7

1.76

1.58

8.80

1655

3786

(3044941) Cell count panel - Synovial fluid

264

16.75

196.14

1.4

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1494

3058

2.56

195.39

3.8

3.0

1.23

mmol/l

0.75

1304

2602

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2404

6097

2.10

195.06

3.0

6.86

9.11

umol/l

4.86

2049

5330

(3018405) Lactate [Moles/volume] in Arterial blood

694

864

4.13

193.94

4.2

3.3

1.37

1.41

mmol/l

0.30

680

853

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

218

30.69

191.61

1.6

1.1

52.78

58.39

0.30

129

(3015235) Bicarbonate [Moles/volume] in Capillary blood

571

612

4.78

188.56

3.3

3.0

24.41

24.34

mmol/l

0.11

560

591

(3014007) Fractional oxyhemoglobin in Arterial blood

1152

2089

2.86

187.90

10.5

9.9

94.05

94.74

2.54

1145

2084

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

809

1165

3.58

187.73

1.6

1.5

0.24

1.96

iu/ml

0.46

138

263

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

895

1393

3.32

186.03

3.7

3.2

1.46

1.26

3.42

890

1387

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1327

2666

2.59

179.54

1.8

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1161

2180

2.77

177.99

5.7

4.5

24.18

24.06

mmol/l

0.67

1142

2151

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

786

1158

3.50

176.64

4.2

3.0

53.16

47.62

5.41

777

1143

(3017143) Hepatitis C virus Ab [Presence] in Serum

3558

10681

1.80

176.58

1.7

1.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

234

17.19

175.53

1.4

1.2

70.38

76.86

—

(3005322) IgE [Units/volume] in Serum or Plasma

1769

4133

2.25

174.11

1.3

1.2

241.02

319.68

u/ml

1.27

1635

3823

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

482

479

5.14

171.77

1.2

1.1

4.69

7.81

u/ml

0.17

(3027273) Bicarbonate [Moles/volume] in Venous blood

828

1303

3.27

169.15

3.8

2.7

25.20

25.18

mmol/l

0.05

803

1254

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

254

101

12.76

169.10

1.2

1.0

—

(3000494) Fungus identified in Specimen by Culture

2334

6167

2.00

168.67

1.5

1.3

—

(36660697) Celiac disease serology panel - Serum

2165

5564

2.06

168.43

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

583

707

4.22

167.91

1.9

1.1

3.96

2.09

iu/l

4.62

220

172

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2117

5443

2.05

164.31

2.5

2.3

6151.79

7223.52

u/l

0.64

781

2468

(1616796) Gas panel - Central venous blood

532

609

4.47

163.59

3.6

2.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1945

4849

2.11

163.33

4.2

4.5

235.93

250.97

u/l

1.69

1840

4660

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1057

1978

2.77

162.77

1.6

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

578

715

4.14

162.60

2.1

2.0

3.59

3.69

g/l

0.75

538

649

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

578

716

4.13

162.33

2.1

2.0

7.25

7.02

g/l

1.83

538

651

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

578

716

4.13

162.33

2.1

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1219

2472

2.56

161.59

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

1324

2805

2.46

160.79

3.0

2.7

72.53

67.03

e9/l

4.32

977

1977

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5873

20661

1.58

159.47

1.8

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1239

2551

2.52

159.36

3.2

2.6

146.95

177.72

ng/l

1.59

1074

2309

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

535

644

4.25

155.37

1.2

1.1

50.10

26.33

u/ml

1.30

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

554

688

4.12

155.09

2.1

2.0

2.85

2.95

g/l

1.05

514

622

(3036489) Thrombin time

1042

2002

2.69

152.83

3.2

2.4

21.32

21.43

0.18

884

1731

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1800

4471

2.11

152.11

2.4

2.6

0.22

g/l

0.33

1682

4230

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

966

1804

2.76

149.10

10.8

10.6

24.30

24.23

mmol/l

0.24

949

1746

(3023183) Ammonium ion [Moles/volume] in Plasma

544

691

4.03

148.18

2.9

33.23

37.56

umol/l

2.69

505

643

(3010421) pH of Blood

610

849

3.68

147.94

3.9

2.7

7.42

0.73

546

788

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

230

100

11.66

146.83

1.2

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

1018

1984

2.65

145.30

3.2

2.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1900

4929

2.02

143.09

1.2

133.40

147.83

iu/ml

0.61

706

1829

(4200892) Spirometry reversibility

1358

3079

2.29

142.17

1.4

1.3

—

(3017732) Neutrophils [#/volume] in Blood

1545

3704

2.18

142.10

2.5

2.1

5.00

4.20

e9/l

1.47

1319

3210

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

226

104

11.01

140.24

1.8

1.4

—

(4146454) Self-monitoring of blood glucose

178

19.57

139.47

2.8

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

519

677

3.92

136.78

2.2

2.0

10.27

10.50

g/l

0.38

479

607

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

668

1056

3.24

135.30

2.2

1.8

1.69

2.24

ug/l

0.38

596

942

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

188

15.10

134.52

1.6

1.0

6.28

5.09

u/l

0.87

155

(3028626) Oxygen [Partial pressure] in Capillary blood

716

1189

3.09

134.43

6.2

6.6

8.96

9.10

kpa

0.91

694

1154

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1887

4999

1.98

133.84

2.6

2.3

60.66

46.79

u/l

0.22

1613

4376

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

164

22.41

133.73

1.5

1.1

37.88

29.86

0.59

(3021901) Oxygen saturation in Capillary blood

394

411

4.88

133.71

2.8

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1160

2518

2.38

133.35

1.5

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

489

624

4.00

132.42

2.4

2.2

0.71

1.14

g/l

1.01

447

542

(3013290) Carbon dioxide [Partial pressure] in Blood

531

724

3.75

132.25

3.9

2.8

5.02

4.92

kpa

1.79

521

706

(3012501) Base excess in Blood by calculation

531

724

3.75

132.25

3.9

2.8

2.24

2.35

mmol/l

0.31

327

432

(3027315) Oxygen [Partial pressure] in Blood

530

727

3.72

130.97

3.9

2.7

9.10

9.00

kpa

0.42

520

709

(40767503) Oxygen content in Capillary blood by calculation

479

609

4.01

130.29

2.4

1.8

17.14

17.05

0.13

251

234

(3007930) Methemoglobin/Hemoglobin.total in Blood

712

1205

3.03

129.66

7.0

4.6

0.91

0.92

0.18

665

1108

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

353

344

5.22

128.18

1.3

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

716

1230

2.99

127.25

7.0

4.6

1.81

1.71

0.98

668

1126

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

207

10.69

126.59

1.1

5.83

0.11

nmol/l

1.50

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2091

5855

1.87

125.99

4.0

2.9

30.78

32.52

9.76

1614

4041

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1440

3522

2.13

125.66

2.4

2.1

75.85

77.89

ml/min/173m2

0.84

556

1150

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

973

2010

2.50

123.76

12.1

9.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

127

58.29

123.47

2.6

3.2

28.47

27.00

umol/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

616

986

3.20

122.37

2.0

2.1

10.72

9.99

mg/l

0.84

576

935

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

448

577

3.96

119.93

2.2

2.0

38.64

38.59

g/l

0.04

408

511

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

443

568

3.97

119.25

2.2

2.0

0.01

0.05

g/l

0.52

418

520

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

574

894

3.28

118.80

1.3

4.35

3.87

iu/ml

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

14.07

116.21

1.2

1.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

579

922

3.21

115.90

1.4

1.3

305.69

295.83

ug/g

0.38

300

507

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1874

5240

1.87

112.81

2.5

1.9

11.84

12.74

nmol/l

4.00

1702

4862

(3047181) Lactate [Moles/volume] in Blood

644

1119

2.95

112.24

7.6

4.8

1.24

1.25

mmol/l

0.03

564

974

(3004616) Nuclear Ab [Presence] in Serum

279

244

5.80

111.95

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

408

517

4.02

111.42

2.3

2.1

0.00

g/l

0.50

384

470

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

350

389

4.57

111.12

1.7

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

604

1016

3.04

110.98

1.7

1.4

—

(40761536) Microorganisms panel - Urine sediment

1896

5350

1.85

110.91

3.9

2.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

155

15.06

110.88

1.3

1.0

156323.23

48450.91

e6/l

0.80

101

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

405

513

4.02

110.65

2.3

2.1

0.00

g/l

-0.00

383

470

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

169

12.20

110.46

1.1

1.0

217.97

87.40

ng/l

0.76

(44816559) Phosphatidylethanol [Mass/volume] in Blood

676

1221

2.83

110.32

1.4

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1097

2533

2.23

109.55

1.1

1.02

16.83

u/ml

0.86

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

125

30.04

109.47

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15519

69067

1.42

108.97

3.8

3.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

504

766

3.36

108.09

1.3

1.2

4.51

3.94

u/ml

0.31

229

354

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

522

818

3.26

107.03

1.3

1.2

4.98

2.38

u/ml

1.31

181

264

(40768804) Tissue Pathology biopsy report

7147

27988

1.41

105.11

2.0

1.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

505

789

3.26

104.00

1.3

1.2

—

(3022145) Colonoscopy Study observation

2085

6184

1.76

103.54

1.3

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

309

330

4.75

102.37

1.6

1.2

1.28

1.56

promille

1.65

236

255

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

733

1455

2.58

100.63

1.9

1.8

1.46

1.31

g/l

3.39

640

1238

(3025941) Bacteria identified in Stool by Culture

1392

3650

1.98

100.57

1.3

1.2

—

(3011288) Drugs identified in Urine by Screen method

1448

3856

1.95

100.16

3.7

1.9

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

137

15.72

99.68

1.2

13.93

12.40

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2200

6704

1.72

99.29

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

584

1040

2.87

97.60

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

655

1248

2.68

97.11

2.1

1.6

195.86

207.20

pmol/l

1.36

627

1204

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

887

1968

2.31

96.77

4.5

2.9

96.05

90.15

10.24

858

1890

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

17.46

96.72

1.1

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1181

2962

2.06

96.05

1.6

1.4

7.95

8.34

u/l

0.54

950

2343

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

386

530

3.70

95.24

3.0

3.7

39.97

34.18

mg/l

0.28

310

447

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

378

511

3.76

95.18

2.9

3.7

1.44

1.73

ratio

0.43

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

127

16.87

94.82

1.1

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

386

532

3.69

94.77

3.0

3.7

47.01

45.84

mg/l

0.07

313

449

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

488

793

3.14

94.66

1.1

115.69

112.89

0.97

450

700

(3039162) Centromere protein B Ab [Units/volume] in Serum

294

323

4.62

94.54

1.2

1.1

62.43

16.93

u/ml

1.50

(3003338) MCHC [Mass/volume]

16874

76896

1.41

94.23

17.6

8.7

333.74

g/l

0.01

16775

76050

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

519

881

3.00

93.94

1.7

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

529

912

2.96

93.35

1.7

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

365

491

3.78

92.50

2.0

1.5

1.75

1.80

mmol/l

0.24

358

481

(3030981) Hyaline casts [#/volume] in Urine by Automated count

975

2309

2.17

91.46

3.0

2.0

0.25

0.30

e6/l

0.62

947

2235

(3052851) Hemolysis interference index of Serum or Plasma

637

1237

2.63

91.13

2.8

2.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

574

1057

2.77

90.48

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

145

10.93

89.86

1.1

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

554

1006

2.81

89.51

6.2

4.3

0.35

0.32

u/ml

1.02

317

524

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

120

16.36

88.65

1.1

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

522

922

2.89

88.45

2.9

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

222

197

5.70

88.00

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

121

15.65

87.94

1.1

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1600

4592

1.81

87.92

2.7

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

120

15.93

87.79

1.1

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1384

3795

1.89

87.59

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4586

17044

1.44

86.48

2.4

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

501

876

2.91

86.35

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

805

1803

2.29

85.90

3.5

2.6

165.74

174.28

1.87

768

1714

(3045414) Leukocytes [Presence] in Urine

880

2061

2.19

84.69

1.7

1.5

—

(3018572) Chloride [Moles/volume] in Blood

442

729

3.09

83.77

9.4

6.2

105.66

105.22

mmol/l

0.90

398

639

(3039000) Anion gap in Blood

441

729

3.08

83.29

9.4

6.2

11.34

11.18

mmol/l

0.38

397

639

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

781

1753

2.28

82.91

1.2

1.1

—

(3000492) Spirometry study

2173

6915

1.64

82.68

1.4

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

491

871

2.87

82.59

3.6

56.32

55.96

0.23

491

871

(3011412) CD3 cells [#/volume] in Blood

317

422

3.81

81.45

3.0

2.1

1.36

1.30

e9/l

0.42

271

341

(3034770) Mitochondria Ab [Titer] in Serum

662

1388

2.44

81.39

1.2

1.4

643.00

1005.90

titre

0.84

(3020961) Endomysium IgA Ab [Titer] in Serum

1338

3716

1.86

81.31

1.1

226.70

250.08

titre

0.09

144

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

357

522

3.47

80.92

2.5

2.4

—

(3006653) Thiamine [Moles/volume] in Blood

151

8.47

80.90

1.4

1.5

132.13

131.56

nmol/l

0.03

151

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

295

374

4.00

80.57

1.5

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

174

130

6.76

79.58

1.2

1.1

46.37

18.57

u/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4125

15239

1.44

79.34

4.0

4.2

2.14

3.15

ug/l

3.39

3714

13997

(3035637) Corticotropin [Mass/volume] in Plasma

396

637

3.16

78.05

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1462

4232

1.79

77.82

1.7

1.6

314.77

324.30

mu/l

0.33

1321

3753

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4964

19024

1.40

77.58

2.5

2.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

6347

25331

1.36

77.50

2.1

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

667

1437

2.37

77.44

1.2

1.4

108.27

119.69

titre

0.11

130

(3006184) Hemoglobin [Mass/volume] in Capillary blood

461

819

2.86

77.35

2.2

1.9

133.91

133.04

g/l

0.28

358

640

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

901

2218

2.08

76.62

2.0

1.5

35.81

43.45

nmol/l

14.52

878

2192

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

373

584

3.24

76.60

2.4

3.1

22.13

21.93

nmol/l

0.10

353

566

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

385

620

3.15

75.76

1.8

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

323

462

3.55

75.50

1.3

0.21

0.14

nmol/l

0.36

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

283

366

3.92

75.44

8.0

6.4

10.35

10.24

mg/l

0.12

258

346

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1320

3741

1.82

75.16

2.1

1.7

—

(3003181) Sodium [Moles/volume] in Urine

312

437

3.62

75.03

1.4

1.7

67.81

67.39

mmol/l

0.04

268

330

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

149

7.68

74.81

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

704

1581

2.28

74.60

3.3

3.6

0.32

0.19

g/l

2.69

320

858

(3024980) IgG subclass 4 [Mass/volume] in Serum

425

739

2.92

73.95

1.6

0.74

0.80

g/l

0.33

319

575

(4062490) Immunoglobulin typing, IgG

297

407

3.70

73.53

1.4

1.2

—

(3008295) Osmolality of Serum or Plasma

260

322

4.09

73.08

1.6

2.0

285.13

280.82

mosm/kgh2o

1.68

198

275

(40760888) Immunoglobulin light chains.free panel - Serum

290

393

3.74

72.86

2.9

3.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

365

583

3.18

72.74

1.5

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1209

3366

1.85

72.73

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

137

8.33

72.67

2.4

1.8

15.25

13.70

umol/l

0.57

137

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

371

601

3.13

72.35

3.5

2.3

—

(3022621) pH of Urine by Test strip

1239

3489

1.83

71.92

2.7

2.1

—

(3024928) Oxygen saturation in Venous blood

435

780

2.84

71.85

4.3

4.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

294

407

3.66

71.83

1.4

1.2

0.39

0.38

g/l

0.17

204

284

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

778

1854

2.15

71.71

1.9

1.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

205

208

4.98

71.67

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

205

208

4.98

71.67

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

294

408

3.65

71.60

1.4

1.2

2.95

2.99

g/l

0.11

204

286

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

205

209

4.96

71.33

1.2

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

294

410

3.63

71.14

1.4

1.2

6.53

6.69

g/l

0.26

206

285

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

295

413

3.62

71.01

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

321

478

3.41

70.95

1.3

0.55

0.57

nmol/l

0.42

310

458

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

103

13.32

70.17

1.1

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

325

493

3.34

69.95

1.7

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

202

207

4.93

69.93

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

202

208

4.91

69.60

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

202

208

4.91

69.60

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

838

2082

2.06

69.52

2.3

2.2

—

(3037756) Immunofixation for Serum or Plasma

274

370

3.75

69.18

1.4

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

810

1990

2.08

69.17

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

716

1676

2.18

68.89

1.8

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

905

2324

2.00

68.76

1.7

—

(3022806) Fractional oxyhemoglobin in Capillary blood

297

428

3.52

68.74

1.9

1.5

91.31

90.81

0.85

292

423

(3014148) Varicella zoster virus Ab [Titer] in Serum

525

1070

2.50

68.36

1.2

—

(3016879) Cocaine [Presence] in Urine

1806

5760

1.62

67.45

2.6

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

491

981

2.55

66.50

6.4

4.2

608.08

492.70

iu/ml

0.20

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2605

9085

1.50

65.83

1.8

2.0

—

(3004775) Volume in Urine collected for unspecified duration

117

9.08

65.53

2.2

1.8

638.46

730.41

0.87

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

255

341

3.79

65.22

3.1

2.2

545.82

550.40

e6/l

0.03

202

260

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5010

19700

1.36

64.98

1.8

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

344

574

3.04

64.07

1.1

95.14

93.87

0.30

328

534

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

657

1535

2.18

63.48

7.5

5.3

1.35

1.12

mg/l

11.14

624

1456

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

446

869

2.61

63.40

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

446

869

2.61

63.40

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

935

2506

1.91

62.91

1.8

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

249

340

3.71

62.00

3.1

2.2

0.22

0.23

e9/l

0.45

203

259

(3023419) Bacteria identified in Sputum by Culture

259

368

3.56

61.17

3.3

2.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

247

341

3.67

60.63

1.6

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

279

421

3.36

60.56

1.5

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

255

361

3.58

60.52

2.9

1.8

73.37

70.40

1.50

246

353

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

649

1539

2.15

60.50

1.3

241.43

226.61

u/ml

0.64

409

982

(3000764) Benzodiazepines [Presence] in Urine

1897

6283

1.56

60.32

2.6

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

166

163

5.14

60.01

3.9

2.1

207.60

136.20

umol/l

1.31

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

104

9.53

59.98

1.0

269.45

259.27

ng/l

0.08

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

104

9.53

59.98

1.0

41.21

28.03

ng/l

1.64

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3087

11325

1.43

59.75

2.1

2.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

383

715

2.72

58.96

3.9

3.2

1164.73

1019.69

u/ml

0.05

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

377

700

2.73

58.61

1.7

1.6

—

(3028300) Cannabinoids [Presence] in Urine

1905

6357

1.55

58.55

2.6

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

251

360

3.53

58.54

2.8

1.8

12.69

12.56

0.06

245

352

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

377

701

2.73

58.46

1.7

1.6

—

(3011985) Renin [Units/volume] in Plasma

310

515

3.05

58.18

1.6

1.8

60.85

71.93

mu/l

0.23

282

473

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

294

473

3.15

58.02

1.5

718.01

401.35

pmol/l

0.44

254

426

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

421

835

2.56

57.86

1.4

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

297

482

3.12

57.83

1.5

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

669

1637

2.08

57.67

1.3

—

(3027008) Opiates [Presence] in Urine

1898

6352

1.55

57.55

2.4

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

260

388

3.39

57.37

1.4

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

101

9.09

56.67

1.0

723.09

906.68

ng/l

1.31

(3040151) Glucose [Moles/volume] in Capillary blood

253

375

3.41

56.37

5.4

2.2

7.03

5.85

mmol/l

5.76

218

290

(3044927) Protein electrophoresis panel - Urine

138

119

5.85

56.24

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

239

343

3.53

55.72

2.8

1.9

—

(3036180) Methadone [Presence] in Urine

278

443

3.18

55.69

3.6

2.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

539

1228

2.23

55.25

1.4

1.3

19.29

22.75

u/l

1.57

447

1035

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

759

1979

1.96

55.20

4.4

2.7

3.42

3.50

g/l

0.67

719

1886

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

189

230

4.15

54.35

1.7

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

380

741

2.60

53.98

1.8

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

603

1455

2.11

53.85

1.5

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

22.15

53.75

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

178

209

4.30

53.36

1.2

1.1

23.92

5.94

u/ml

0.67

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

17.62

53.16

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

17.62

53.16

1.1

1.0

—

(3027944) Amphetamines [Presence] in Urine

1854

6282

1.53

52.98

2.5

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1455

4677

1.60

52.19

1.1

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

10.19

52.14

1.1

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

10.19

52.14

2.0

1.1

137.73

6.06

ug/min

1.11

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

224

322

3.52

52.13

1.1

1.04

1.06

ratio

0.65

112

(3016750) Collection duration of Urine

8.18

52.03

2.1

1.9

503.74

500.09

min

0.10

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

601

1471

2.08

51.77

1.5

1.4

21.38

19.53

u/ml

0.11

(3020876) Protein [Mass/time] in 24 hour Urine

176

211

4.21

51.53

2.4

1.99

0.89

g/24h

2.05

101

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2494

9022

1.44

51.47

2.0

1.9

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

13.80

51.26

1.1

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

262

427

3.10

50.73

1.8

1.4

—

(3024263) Appearance of Synovial fluid

9.07

50.47

1.6

1.1

—

(4034850) Laboratory test

637

1612

2.01

50.28

9.2

5.4

—

(3000034) Microalbumin [Mass/volume] in Urine

163

187

4.40

50.19

3.5

1.8

60.42

60.26

mg/l

0.00

127

117

(40768443) Skin Pathology biopsy report

816

2258

1.85

49.79

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

10.20

49.76

1.4

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

151

164

4.65

49.35

1.6

4.00

3.09

nmol/l

0.17

119

137

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

236

368

3.24

48.91

1.1

1.0

287.92

290.70

mg/l

0.16

213

345

(3016244) Insulin [Units/volume] in Serum or Plasma

278

483

2.91

48.56

3.5

3.4

31.95

23.29

mu/l

1.90

264

451

(3008037) Lactate [Moles/volume] in Venous blood

319

605

2.67

47.78

3.2

2.2

1.49

1.41

mmol/l

0.66

311

591

(3000330) Specific gravity of Urine by Test strip

776

2152

1.84

47.02

3.2

2.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

565

1409

2.04

46.38

1.5

1.4

107.35

102.43

u/ml

0.61

108

273

(3014765) Yersinia sp identified in Stool by Organism specific culture

647

1701

1.94

45.96

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

650

1719

1.93

45.40

1.2

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

328

649

2.56

45.37

2.0

5.20

5.89

mmol/24h

2.53

295

589

(3016650) Hepatitis A virus Ab [Presence] in Serum

463

1079

2.18

45.05

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

641

1696

1.92

44.71

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

129

133

4.89

44.54

2.5

2.3

55.38

127.26

umol/l

3.00

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

773

2190

1.80

43.76

1.1

4.08

5.78

u/ml

0.69

105

425

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

437

1007

2.20

43.68

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

277

512

2.74

43.52

1.7

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

275

507

2.74

43.41

1.2

30.79

35.79

u/l

0.20

239

446

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

277

513

2.73

43.37

1.7

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

707

1960

1.84

42.88

1.2

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

128

136

4.75

42.87

1.2

1.1

4.27

2.79

iu/ml

1.43

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3181

12362

1.34

42.11

3.7

3.5

21.08

21.09

0.02

1269

5434

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

184

269

3.45

41.93

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

196

300

3.30

41.82

3.1

2.9

0.85

0.80

nmol/l

0.46

152

220

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

8.36

41.64

1.1

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

288

560

2.60

41.24

3.3

2.2

7.32

6.30

mmol/l

4.79

282

550

(3024666) Lithium [Moles/volume] in Serum or Plasma

247

442

2.83

41.11

10.4

11.6

0.58

0.62

mmol/l

1.45

224

407

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

225

383

2.97

40.74

3.0

2.8

41975.21

41990.86

ug/l

0.00

225

383

(40768446) Kidney Pathology biopsy report

101

5.72

40.50

1.8

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1464

4993

1.51

40.20

1.4

19.72

24.88

iu/l

7.96

1233

4181

(3003694) ABO and Rh group [Type] in Blood

6244

26613

1.25

40.20

1.6

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

6.59

40.18

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3373

13313

1.32

39.94

1.6

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

159

220

3.65

39.09

1.6

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

15.69

38.65

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

7.41

38.43

1.5

1.3

122.35

97.21

nmol/l

0.54

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

257

489

2.66

38.36

1.2

1.3

—

(3045424) Erythrocytes [Presence] in Urine

341

752

2.30

37.75

1.5

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.36

37.49

3.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

138

177

3.93

37.40

1.7

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

115

126

4.60

37.35

1.4

93.64

247.78

nmol/24h

0.51

115

126

(3026250) Tacrolimus [Mass/volume] in Blood

124

146

4.28

37.20

40.1

36.2

7.56

7.24

ug/l

0.80

112

131

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

15.09

36.66

1.2

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

168

254

3.34

36.56

3.1

1.9

11.67

15.95

2.25

162

245

(21494890) Protein electrophoresis panel - 24 hour Urine

133

169

3.97

36.48

1.9

2.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

207

359

2.91

36.40

1.2

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

168

255

3.32

36.36

1.1

95.25

89.31

1.55

138

186

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

206

357

2.91

36.27

1.2

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

355

812

2.21

36.18

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

227

417

2.75

36.15

2.0

1.6

24.20

32.60

mg/l

0.94

101

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

129

162

4.01

35.90

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

125

153

4.12

35.87

1.2

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

481

1247

1.96

35.60

2.2

2.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

5.38

35.38

1.1

1.3

0.06

0.64

g/l

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

184

303

3.07

35.21

2.4

2.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

105

112

4.72

35.11

2.5

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

326

729

2.26

35.01

1.1

1.45

1.47

g/l

0.29

297

683

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

18.86

34.96

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

143

201

3.59

34.48

3.0

1.9

224.21

591.70

e6/l

1.21

106

(3010375) cycloSPORINE [Mass/volume] in Blood

128

167

3.86

34.01

23.5

23.6

115.44

149.78

ug/l

2.32

103

150

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

173

281

3.11

33.85

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

173

281

3.11

33.85

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

173

281

3.11

33.85

1.5

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

177

293

3.05

33.62

1.1

1.0

1481.54

1340.19

miu/ml

0.76

177

293

(3033705) Calcium.ionized [Moles/volume] in Venous blood

173

284

3.07

33.30

2.6

1.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

246

495

2.51

33.06

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

13.41

32.91

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

13.41

32.91

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

13.41

32.91

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

13.41

32.91

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

465

1226

1.92

32.84

1.1

8.84

11.80

au/ml

0.48

108

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

402

1008

2.02

32.63

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

14.46

32.53

1.1

1.0

—

(3019977) pH of Arterial blood

106

123

4.34

32.39

2.8

1.7

7.43

0.08

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

15.81

32.19

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

397

998

2.02

32.01

1.7

2.0

4178.46

2800.00

titre

0.26

(3042517) Benzodiazepines panel - Urine

5.98

31.77

2.7

2.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

459

1222

1.90

31.53

1.9

2.3

6.89

7.37

titre

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.04

31.45

2.7

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

313

721

2.20

31.44

1.5

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

166

276

3.03

31.34

1.6

1.5

128.93

124.15

0.30

160

262

(3017315) Amylase [Enzymatic activity/volume] in Urine

133

193

3.47

30.76

1.3

1.1

387.91

292.83

u/l

0.43

119

184

(3051593) INR in Capillary blood by Coagulation assay

6.58

30.75

11.1

20.2

—

(3024869) Neuronal Ab [Presence] in Serum

13.83

30.56

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

227

458

2.50

30.39

1.1

1.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

267

584

2.31

30.20

3.5

3.1

1.17

1.77

1.69

245

517

(3013005) Retinol [Moles/volume] in Serum or Plasma

167

287

2.94

29.91

2.2

2.7

1.78

1.72

umol/l

0.42

159

276

(3047007) Chlamydophila sp Ab [Presence] in Serum

403

1045

1.95

29.88

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

207

402

2.60

29.86

3.7

3.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

217

432

2.54

29.84

1.4

11.29

10.79

umol/l

0.51

206

406

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

13.52

29.58

1.1

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

332

804

2.09

29.54

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

111

4.36

29.49

4.7

3.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

131

194

3.40

29.47

1.4

1.3

167.97

163.25

mmol/24h

0.19

131

194

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

110

143

3.88

29.42

1.6

1.2

13.86

13.61

pmol/l

0.23

122

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

7.68

29.38

2.9

2.1

1.20

1.09

mmol/l

0.10

(3005988) Vibrio sp identified in Specimen by Organism specific culture

231

479

2.44

29.28

1.5

1.4

—

(3034426) Prothrombin time (PT)

118

163

3.65

29.20

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

232

483

2.43

29.17

1.5

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

33.80

28.95

1.2

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

230

479

2.43

28.90

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

117

162

3.64

28.87

1.6

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

234

492

2.40

28.83

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

229

478

2.42

28.65

1.5

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

153

256

3.01

28.64

3.0

1.8

27.36

27.01

0.11

148

248

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

229

480

2.41

28.41

1.5

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1379

4970

1.42

28.33

1.4

—

(3042631) Mycobacterium sp identified in Specimen

190

364

2.63

28.15

2.9

2.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

107

142

3.80

27.91

1.6

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

152

260

2.95

27.48

2.5

3.6

1.11

1.47

ug/l

1.15

136

253

(3044242) Glucose [Moles/volume] in Arterial blood

107

4.28

27.46

2.1

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1112

3874

1.46

27.35

1.3

230.91

236.09

miu/ml

0.17

519

1987

(3017569) Oxygen content in Arterial blood

4.85

27.26

2.3

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.46

27.19

1.6

1.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

452

1258

1.82

27.18

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

288

686

2.12

26.76

3.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

105

142

3.72

26.75

1.6

1.4

—

(3002256) Pathology report gross observation

2176

8508

1.31

26.74

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

200

406

2.49

26.52

3.0

3.3

95.99

95.09

0.14

187

375

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.54

26.39

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

120

182

3.32

26.14

1.2

0.29

0.28

g/l

0.26

135

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

120

182

3.32

26.14

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

293

711

2.08

26.00

1.3

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.75

25.95

5.1

6.2

—

(3016038) Potassium [Moles/volume] in Urine

124

194

3.22

25.81

1.3

1.7

35.90

38.36

mmol/l

0.41

116

178

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

130

212

3.09

25.41

1.6

1.5

144.73

139.37

0.28

124

192

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

227

500

2.29

25.37

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

9.05

25.34

1.6

1.2

—

(3028433) Virus identified in Specimen by Culture

129

3.79

25.28

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

167

317

2.66

25.22

1.2

1.7

5.20

7.06

ug/l

2.44

145

288

(3020717) Zinc [Moles/volume] in Serum or Plasma

159

294

2.73

25.19

1.8

1.5

21.63

28.25

umol/l

1.71

151

285

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

193

396

2.46

25.08

1.3

1.2

1.67

4.19

u/ml

2.57

100

234

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

185

373

2.50

24.90

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

10.59

24.57

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

146

261

2.82

24.56

4.0

3.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.77

24.46

3.0

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.77

24.46

3.0

1.6

—

(3007463) Buprenorphine [Presence] in Urine

12.07

23.57

4.8

5.1

—

(3049717) Cytology report of Urine Cyto stain

466

1370

1.72

23.42

2.4

2.7

—

(3017704) Immunofixation for Urine

4.35

23.40

1.5

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

200

435

2.32

23.03

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

121

201

3.03

23.02

1.1

91.57

96.70

0.93

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

622

1987

1.59

22.79

1.2

1.3

—

(3004451) EKG impression Narrative

4.10

22.75

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

10.06

22.72

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

878

3036

1.47

22.42

1.4

—

(3000012) Reticulocyte production index

191

412

2.34

22.41

2.0

2.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

129

227

2.86

22.34

2.1

1.5

3.72

2.96

mg/l

1.05

124

216

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

232

546

2.15

22.29

1.3

5.90

6.08

umol/l

0.24

213

514

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.19

22.19

2.3

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

105

3.88

21.86

1.4

1.3

17.36

17.09

umol/l

0.12

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

102

157

3.27

21.83

1.1

1.3

94.34

81.24

3.14

102

157

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

109

176

3.12

21.71

1.2

106.52

107.61

0.14

160

(3014271) Vancomycin [Susceptibility]

4.40

21.54

2.7

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

109

178

3.08

21.34

1.4

20.40

24.25

u/ml

0.32

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

155

310

2.52

21.28

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

119

206

2.91

21.21

1.2

108.88

106.39

0.22

107

187

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

6.35

21.21

4.1

6.7

2.28

1.77

mg/l

0.76

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

202

460

2.22

21.02

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

895

3146

1.45

21.02

1.5

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

113

192

2.96

20.78

1.1

89.94

97.24

0.98

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

154

3.20

20.37

1.3

1.2

290.00

126.00

titre

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

712

2406

1.50

20.36

1.1

2.34

2.88

u/ml

0.59

394

1322

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

186

415

2.26

20.31

1.1

1.2

58.57

290.00

titre

—

(3000093) Morphology [Interpretation] in Blood Narrative

181

399

2.29

20.30

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

186

417

2.25

20.09

1.1

1.2

166.00

237.18

titre

0.48

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

136

3.33

19.83

1.6

1.5

38310.67

3011.00

u/ml

0.45

(3013293) Extractable nuclear Ab [Presence] in Serum

20.11

19.82

1.6

1.7

—

(3011648) Oxygen content in Venous blood

168

365

2.32

19.48

5.5

5.9

11.75

11.30

0.66

168

365

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

151

3.17

19.43

1.3

1.2

62.22

177.14

titre

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

149

3.18

19.31

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

144

3.22

19.27

1.3

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

108

188

2.89

19.12

1.1

1.3

—

(44813793) Dust mix specific IgE antibody measurement

204

491

2.10

18.64

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

145

3.16

18.57

1.1

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.93

18.39

1.5

1.2

72.45

58.99

ng/l

0.09

(3022689) Creatine [Moles/volume] in Urine

5.36

18.38

1.6

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

335

964

1.76

18.23

4.2

2.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

226

576

1.98

17.79

1.7

1.8

—

(21494755) Public health laboratory ask at order entry panel

2390

14384

0.81

17.77

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

152

333

2.30

17.37

2.9

3.4

53.40

54.88

0.30

134

272

(3016273) Islet cell 512 Ab [Units/volume] in Serum

8.47

17.35

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.84

17.34

1.4

1.6

1.35

3.15

mg/l

1.24

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

128

3.22

17.29

1.2

102.91

101.10

0.17

118

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

121

238

2.56

17.26

2.0

2.6

87.20

618.84

ug/l

0.66

110

223

(3024471) HLA-A [Type]

155

2.99

17.24

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

179

423

2.13

17.16

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.87

17.01

1.6

1.5

9.28

9.39

ug/l

0.05

(3024932) HLA-DR beta [Type]

151

3.00

16.98

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

162

369

2.21

16.96

2.3

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2271

9418

1.23

16.92

2.7

0.71

0.83

ug/l

4.54

1361

5382

(3003888) Timothy IgE Ab [Units/volume] in Serum

635

2180

1.48

16.88

1.1

6.14

6.90

u/ml

0.46

343

1280

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

169

394

2.16

16.75

1.0

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

156

353

2.23

16.60

1.2

76.81

90.53

u/l

0.37

148

321

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

122

3.22

16.42

1.2

1.1

76.30

81.14

0.45

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

167

391

2.15

16.40

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

148

330

2.26

16.29

1.1

397.77

408.08

nmol/l

0.22

138

315

(3008401) Mugwort IgE Ab [Units/volume] in Serum

605

2073

1.48

16.25

1.1

0.93

1.33

u/ml

1.08

284

1040

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.64

15.99

1.4

1.6

2.19

3.20

mg/l

0.34

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.64

15.99

1.4

1.6

3.09

3.76

mg/l

0.23

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.64

15.99

1.4

1.6

0.88

2.02

mg/l

0.92

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.64

15.99

1.4

1.6

0.95

1.53

mg/l

0.89

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.64

15.99

1.4

1.6

2.21

3.26

mg/l

0.44

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.64

15.99

1.4

1.6

1.18

0.92

mg/l

0.22

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.64

15.99

1.4

1.6

2.09

3.08

mg/l

0.36

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.64

15.99

1.4

1.6

3.56

4.03

mg/l

0.16

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.64

15.99

1.4

1.6

2.33

1.89

mg/l

0.16

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.82

15.99

1.3

1.4

295.23

344.92

pmol/l

0.33

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

135

3.06

15.97

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

115

3.24

15.75

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

115

3.24

15.75

1.3

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

206

534

1.95

15.54

1.3

1.6

—

titre

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

139

309

2.27

15.43

3.0

2.5

43.89

37.70

2.87

128

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.28

15.40

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

208

543

1.93

15.39

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.91

15.39

1.4

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

125

3.10

15.35

1.2

1.1

70.63

72.07

0.07

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

100

191

2.64

15.14

1.6

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

100

191

2.64

15.14

1.6

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

151

2.87

15.11

3.8

2.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

198

512

1.95

15.06

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

17.59

14.96

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

419

1351

1.57

14.92

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.91

14.84

4.5

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

168

413

2.05

14.66

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

103

204

2.54

14.58

8.8

4.2

73.51

3111.62

mg/l

1.08

133

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

124

3.04

14.55

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

159

384

2.09

14.53

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.41

14.47

1.7

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

148

2.82

14.24

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

148

2.82

14.24

1.7

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

151

2.80

14.21

1.7

2.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

178

2.63

14.06

2.1

2.4

8.61

10.00

mg/l

1.21

155

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.04

14.03

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

178

455

1.97

14.02

2.8

3.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.41

13.93

8.4

6.2

6.11

5.53

mmol/l

0.26

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4.59

13.87

1.4

1.2

13.66

24.22

nmol/l

1.71

(3006576) Bicarbonate [Moles/volume] in Blood

128

2.95

13.85

6.9

7.2

24.08

24.93

mmol/l

0.90

116

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1010

3888

1.32

13.74

1.7

1.4

4.49

2.92

mg/l

2.22

790

2318

(3051387) C reactive protein [Mass/volume] in Capillary blood

409

1338

1.54

13.72

3.6

2.3

23.20

27.51

mg/l

1.68

263

823

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.83

13.68

1.2

1.0

0.71

0.72

umol/24h

0.05

(3028717) Thiamine [Mass/volume] in Blood

6.56

13.66

1.2

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

113

243

2.34

13.56

1.5

1.3

12.46

10.83

u/l

1.20

107

235

(3029075) Extractable nuclear Ab panel - Serum

139

2.82

13.42

1.1

1.0

—

(3020491) Glucose [Moles/volume] in Blood

173

445

1.96

13.42

1.8

1.4

6.31

5.39

mmol/l

3.97

129

366

(3045142) Bone marrow Pathology biopsy report

177

461

1.93

13.26

1.3

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

527

1834

1.45

13.17

1.6

1.4

0.40

0.46

nmol/l

0.51

419

1506

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

5.99

13.15

1.5

1.4

0.36

0.52

ug/l

0.56

(3043410) Blood group antigens tested for on Red Blood Cells

138

2.81

13.13

1.3

1.4

—

(21494434) Karyotype in Bone marrow

132

309

2.15

13.08

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.94

13.08

1.6

1.4

519451.65

123536.16

nmol/l

0.33

(3019174) dRVVT (LA screen)

5.03

13.05

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

102

213

2.41

13.04

2.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

102

213

2.41

13.04

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.04

12.91

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

125

290

2.17

12.67

1.1

1.0

7.68

15.11

u/ml

1.35

(3051651) Icteric interference index of Serum or Plasma

126

295

2.15

12.50

3.1

3.8

—

(1761868) Lipid panel - Serum or Plasma

6939

32114

1.12

12.50

2.5

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3764

16754

1.15

12.35

1.5

—

(3005033) Fetal Nuchal fold Thickness US

721

4801

0.75

12.31

1.4

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

3.42

12.28

1.3

1.7

200.79

68.64

mu/l

0.49

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1992

11798

0.83

12.22

1.6

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

596

2153

1.40

12.19

1.1

2.02

2.78

u/ml

1.02

320

1204

(3047352) Trisomy 18 risk [Likelihood] in Fetus

726

4816

0.75

12.07

1.4

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

4.64

12.06

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.88

12.05

2.1

2.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

21.10

11.93

1.0

—

(3047189) Immunofixation for 24 hour Urine

3.15

11.76

1.6

2.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.96

11.54

2.0

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

504

1789

1.42

11.41

1.1

5.54

4.43

u/ml

0.32

253

964

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.90

11.33

2.2

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.90

11.33

2.6

1.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

127

2.73

11.29

1.9

2.0

94.11

82.39

au/ml

0.11

(3043238) Trisomy 21 risk [Likelihood] in Fetus

749

4899

0.76

11.26

1.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.59

11.19

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.77

11.13

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

408

1400

1.47

11.04

1.0

1.1

2.83

2.98

u/ml

0.09

201

809

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

408

1401

1.47

11.00

1.1

0.54

0.40

u/ml

0.25

129

371

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

343

1137

1.52

10.95

2.5

2.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

193

553

1.76

10.88

2.4

3.5

3.70

4.47

nmol/l

0.33

188

536

(3032057) Clostridioides difficile [Presence] in Stool

4.04

10.68

1.8

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

467

1657

1.42

10.62

1.1

6.80

6.01

u/ml

0.21

204

784

(3002523) Influenza virus A Ag [Presence] in Specimen

497

1784

1.41

10.60

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.90

10.51

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

136

353

1.94

10.41

2.1

1.7

2.24

1.75

u/field

0.46

164

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

316

1041

1.53

10.40

1.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

495

1782

1.40

10.40

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1374

8297

0.82

10.32

1.4

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

202

2.27

10.31

1.5

1.6

6.74

5.65

u/l

0.25

163

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

187

2.31

10.20

1.1

1.3

16.53

21.62

u/l

0.52

164

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

195

2.27

10.02

1.1

1.3

77.09

124.32

u/l

1.30

179

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

887

3506

1.28

9.99

2.3

3.5

31.80

45.56

u/ml

1.92

851

3426

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

112

276

2.04

9.89

1.8

1.4

2.58

2.40

u/field

0.08

196

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

212

643

1.66

9.82

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.33

9.70

1.2

1.1

1.71

1.49

umol/24h

0.56

(3025018) Bordetella pertussis Ab [Titer] in Serum

163

462

1.78

9.59

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.14

9.56

1.3

1.6

39.05

41.56

umol/l

0.15

(3028679) Herpes simplex virus Ab [Presence] in Serum

179

523

1.72

9.51

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.02

9.48

1.2

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1346

5622

1.21

9.29

1.6

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

130

2.51

9.20

2.2

1.5

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

146

406

1.81

9.16

1.4

1.3

71.38

73.45

0.89

137

388

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

510

1887

1.37

9.15

1.6

1.4

—

(4035726) Immunohistochemistry procedure

1289

5377

1.22

9.02

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

102

2.71

8.97

1.1

1.0

—

(3001556) Androgen free Index in Serum or Plasma

120

2.56

8.93

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

173

2.27

8.92

1.7

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

205

634

1.63

8.87

14.4

13.1

784.41

834.01

nmol/l

0.81

195

610

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

141

394

1.80

8.73

1.4

1.3

421.03

652.92

mu/l

1.76

132

376

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

119

316

1.90

8.62

1.2

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

169

501

1.70

8.58

1.1

6.91

7.29

iu/ml

0.08

148

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.52

8.55

2.3

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

200

621

1.62

8.54

3.4

5.7

149.11

86.34

u/ml

0.51

219

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.80

8.47

1.0

1.1

68.01

83.10

ug/l

1.85

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1044

4290

1.23

8.47

2.1

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

210

662

1.60

8.44

19.3

19.9

1434.58

2821.37

nmol/l

0.47

201

632

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

5.91

8.44

1.3

1.0

10.10

6.59

u/l

0.66

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

472

1753

1.36

8.32

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

101

2.64

8.26

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

124

339

1.84

8.25

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

138

2.37

8.20

2.6

2.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

150

436

1.73

8.18

1.5

1.3

32.31

36.04

g/l

2.33

132

392

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

129

2.42

8.16

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

118

319

1.86

8.13

1.1

1.0

12.58

15.29

u/ml

0.45

201

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.38

8.12

1.0

1.3

33.73

63.71

mg/l

2.44

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.64

8.11

4.7

5.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.53

8.11

2.2

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

194

2.13

8.11

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.82

8.07

1.4

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

113

302

1.88

8.06

1.4

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.77

8.03

1.2

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.11

8.02

1.3

1.2

179.00

126.04

mg/l

0.14

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

3.83

7.93

2.4

1.4

7.84

6.24

mmol/l

0.63

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.62

7.89

1.2

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.62

7.76

4.5

4.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.72

7.74

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

142

414

1.73

7.70

1.5

1.4

2373.21

3751.75

e6/l

0.39

285

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

105

279

1.89

7.65

1.3

1.2

347.11

636.32

u/l

1.47

269

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

177

2.13

7.49

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

113

2.45

7.46

3.6

3.8

68.50

47.01

g/mol

0.21

102

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

148

2.24

7.44

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.81

7.38

1.1

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

952

5763

0.82

7.37

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

954

5767

0.82

7.28

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

951

5749

0.82

7.26

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

948

5730

0.82

7.23

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.78

7.22

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.78

7.22

1.4

1.2

—

(3001729) Color of Synovial fluid

14.06

7.22

1.2

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

530

2053

1.30

7.08

2.4

2.6

5.46

6.79

umol/l

1.49

393

1523

(40757373) Influenza virus identified in Isolate

2.74

7.07

1.7

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

+∞

7.02

1.2

0.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1912

10887

0.87

7.01

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

249

853

1.47

6.98

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

124

2.31

6.90

1.0

0.11

0.23

u/ml

0.50

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

544

2123

1.29

6.89

1.8

1.7

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

113

319

1.78

6.88

2.6

3.4

149.77

164.65

au/ml

0.09

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1027

6130

0.83

6.86

1.4

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.05

6.83

2.6

2.1

26.11

20.85

mg/l

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.43

6.68

5.2

3.7

46.27

44.80

ug/min

0.03

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

418

1581

1.33

6.64

1.4

147.70

117.97

pmol/l

0.32

404

1545

(40765096) Chromosome analysis panel by Banding

111

2.35

6.57

1.2

—

(40768441) Liver Pathology biopsy report

147

457

1.62

6.38

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

117

342

1.72

6.37

2.5

2.2

154.85

150.92

nmol/l

0.14

292

(3000919) Neutrophils/100 leukocytes in Pleural fluid

2.68

6.36

1.2

1.3

29.21

23.07

0.54

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.27

6.26

1.1

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.43

6.24

1.2

1.3

59.58

59.40

0.01

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

141

2.14

6.14

1.0

1.1

1.67

4.46

u/ml

0.41

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

143

2.11

5.94

1.0

1.1

0.08

1.67

u/ml

1.27

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.51

5.94

1.3

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.62

5.94

1.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

12.05

5.93

4.2

420.83

361.40

umol/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

104

2.32

5.91

1.1

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.81

5.85

1.3

23.20

501.25

titre

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.27

5.82

1.4

1.3

1.24

1.72

ml/s/173m2

1.13

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

9.33

5.75

1.2

1.0

—

mmol/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

117

353

1.67

5.74

1.4

1.3

6.12

5.31

mmol/l

3.41

110

323

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

380

1.64

5.74

1.5

1.4

122306.49

36181.60

e6/l

0.79

227

(3019897) Erythrocyte distribution width [Ratio] by Automated count

389

1491

1.32

5.71

2.3

1.7

13.10

12.98

1.49

383

1465

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.71

5.68

4.9

4.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

4.31

5.68

1.1

1.5

0.73

0.92

umol/24h

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.55

5.66

1.5

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.81

5.66

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

6.18

5.60

1.5

1.6

524.41

362.17

nmol/l

0.47

(3035880) pH of Pleural fluid

171

1.97

5.59

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

120

368

1.64

5.55

3.1

4.1

7.69

9.01

mg/l

1.50

307

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

127

2.14

5.55

5.3

3.7

—

(3020393) Adenovirus Ag [Presence] in Stool

108

2.23

5.47

1.8

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

191

1.90

5.40

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

109

2.21

5.37

1.0

0.01

0.02

u/ml

0.39

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.03

5.35

7.2

7.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

192

1.89

5.33

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

192

1.89

5.33

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.73

5.27

1.0

0.16

0.18

u/ml

0.06

(3012494) Peanut IgE Ab [Units/volume] in Serum

126

397

1.60

5.26

1.1

1.2

3.80

34.44

u/ml

0.85

277

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.51

5.25

1.0

0.18

4.37

u/ml

1.30

(3048879) Bone marrow aspiration report

2.63

5.25

2.2

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3811

17780

1.09

5.11

1.8

1.7

—

(3012441) Differential panel - Pleural fluid

117

366

1.61

5.05

1.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

461

2877

0.80

4.92

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.83

4.88

1.5

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

3.12

4.86

1.0

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

2.70

4.85

1.2

23.23

25.02

0.10

(3045788) Cell count panel - Pleural fluid

110

343

1.61

4.83

1.6

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

5.38

4.83

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

223

1.76

4.70

1.2

11.38

13.82

u/l

0.87

214

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.02

4.70

6.6

7.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

3.04

4.68

1.0

1.1

0.08

0.89

u/ml

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

+∞

4.68

1.2

0.0

1.18

—

mg/l

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

4.68

1.2

0.0

23.03

—

mg/l

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

10.04

4.67

1.0

—

(40768806) Pleura Pathology biopsy report

116

370

1.58

4.66

1.6

1.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.32

4.65

1.2

1.3

3.62

3.43

0.03

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

161

555

1.46

4.55

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

163

1.88

4.54

1.0

1.1

1.84

5.45

u/ml

1.65

137

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

110

349

1.59

4.53

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.48

4.44

1.4

1.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

129

1.99

4.44

1.0

1.1

0.60

0.65

u/ml

0.03

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

5.02

4.33

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

330

1290

1.29

4.30

1.4

1.5

6.82

6.18

mmol/l

4.48

297

1151

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

6.03

4.26

2.8

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

289

1.62

4.20

1.4

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.56

4.14

1.1

1.46

2.11

mmol/l

1.57

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.23

4.03

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

3.91

4.00

5.1

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.91

4.00

3.0

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.49

3.98

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.28

3.90

1.3

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

3.28

3.90

2.8

4.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

130

1.89

3.79

6.5

6.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.21

3.78

1.7

1.8

15.58

24.77

pmol/l

1.21

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.38

3.77

1.0

0.09

1.34

u/ml

1.35

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.52

3.74

2.4

3.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

6.28

3.72

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

287

1.58

3.71

1.1

1.2

3.10

14.78

u/ml

2.79

210

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.42

3.65

1.4

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

4.35

3.65

1.0

1.1

0.07

u/ml

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.51

3.59

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.63

3.58

1.8

1.2

—

(40768800) Prostate Pathology biopsy report

179

1203

0.74

3.56

1.3

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.52

3.53

1.1

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.05

3.52

1.4

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

8.03

3.47

1.5

1.0

4.92

2.59

mu/l

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

5.58

3.47

1.5

1.2

—

(3014891) Appearance of Pleural fluid

2.57

3.30

1.4

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

485

0.62

3.27

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

119

1.86

3.27

6.6

5.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.02

3.24

3.3

2.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

357

1463

1.23

3.23

1.2

—

(3013931) Oligosaccharides [Presence] in Urine

6.70

3.17

1.1

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.65

3.16

1.1

0.16

1.16

u/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

332

1.48

3.15

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.87

3.04

1.2

1.0

—

(3006462) Nitrate [Presence] in Urine

282

1.52

3.02

2.1

2.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.13

3.01

8.5

7.8

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

3.26

2.99

1.1

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.40

2.91

1.1

1.0

1.10

0.87

mmol/l

0.13

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

301

1.49

2.91

7.4

8.9

970.05

7883.55

u/ml

0.52

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

7.03

2.90

1.3

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.77

2.88

3.6

6.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

209

1.59

2.88

2.1

1.7

0.17

0.21

nmol/l

0.30

152

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

199

773

1.30

2.87

1.5

1.3

217.65

202.13

pmol/l

0.13

199

773

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.00

2.85

1.0

1.1

22.51

15.08

u/ml

0.23

(3017509) Phencyclidine [Presence] in Urine

140

1.72

2.85

1.4

1.8

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

103

1.85

2.84

1.0

1.1

4.25

10.54

u/ml

2.33

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.18

2.83

1.2

1.0

—

(3016135) IgD [Mass/volume] in Serum

3.86

2.65

1.5

1.0

74.96

32.16

mg/l

—

(40759632) Porphyrins [Mass/mass] in Stool

5.86

2.63

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

585

0.69

2.63

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.81

2.60

1.0

—

(3002619) Bacteria identified in Specimen by Culture

103

1.80

2.58

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

261

1601

0.82

2.56

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.83

2.56

2.9

3.9

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.93

2.55

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

144

546

1.33

2.52

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1303

7133

0.91

2.50

1.5

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

250

1.49

2.49

1.1

1.2

9.69

5.69

u/ml

0.18

237

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.84

2.46

1.8

1.2

11.57

13.39

g/l

0.41

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.25

2.45

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.02

2.40

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.77

2.38

4.1

5.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

971

5372

0.90

2.34

1.5

1.6

—

(3000285) Sodium [Moles/volume] in Blood

2.18

2.32

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

126

1.67

2.32

1.3

1.5

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.07

2.31

3.9

3.2

4.61

4.54

mmol/l

0.14

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.60

2.30

1.1

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.87

2.27

1.1

1.2

56.33

373.54

ug/l

1.28

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

174

1.56

2.27

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

191

1192

0.80

2.26

3.6

3.3

26.75

36.47

u/ml

0.73

186

1149

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.17

2.19

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.76

2.19

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.43

2.18

3.2

4.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.65

2.11

3.4

1.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

5.02

2.11

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

130

1.62

2.10

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1155

5331

1.09

2.08

3.6

4.9

11.86

38.46

ug/l

2.46

908

4145

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

570

0.73

2.07

6.6

6.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

570

0.73

2.07

3.3

3.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.35

2.06

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

126

485

1.31

2.05

1.4

1.5

5.35

5.04

mmol/l

3.49

119

468

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.51

2.02

1.0

0.06

0.37

u/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

183

742

1.24

1.98

1.1

0.40

1.07

u/ml

1.12

232

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.01

1.94

1.1

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.01

1.94

2.4

2.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.01

1.94

5.2

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

157

1.54

1.94

2.7

1.6

934.05

1304.87

e6/l

0.40

101

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.34

1.92

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

170

1.51

1.90

1.1

10.74

9.01

u/ml

0.11

146

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

365

1.34

1.87

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.51

1.87

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.97

1.85

4.8

2.9

2.40

1.63

mg/l

0.24

(3014599) Egg white IgE Ab [Units/volume] in Serum

195

804

1.22

1.83

1.1

3.54

7.29

u/ml

0.53

256

(3033093) Yersinia sp IgM Ab [Titer] in Serum

5.02

1.82

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

5.02

1.82

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

5.02

1.82

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

5.02

1.82

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

5.02

1.82

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

5.02

1.82

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

5.02

1.82

5.4

1.8

136.80

139.60

mmol/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.08

1.81

1.1

27.58

18.62

u/l

0.41

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.83

1.81

1.1

4.69

2.32

u/ml

0.33

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.27

1.80

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

231

1.41

1.78

1.5

1.3

—

(4281824) Cell count and differential, peritoneal fluid

128

809

0.79

1.77

1.2

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.33

1.77

1.0

0.10

0.32

u/ml

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.79

1.75

4.7

5.7

0.25

0.20

mmol/l

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

2.41

1.74

1.0

0.19

0.11

u/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

908

4958

0.92

1.74

1.8

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

2.51

1.72

1.0

0.25

0.28

u/ml

—

(4212803) Bone marrow aspirate examination

2.51

1.63

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.67

1.62

1.5

1.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.18

1.62

1.2

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

100

1.61

1.60

1.1

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.40

1.60

1.0

0.17

0.09

u/ml

—

(3049233) Organic acids panel - Urine

2.13

1.59

1.1

—

(40768793) Breast Pathology biopsy report

303

1748

0.87

1.58

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

104

408

1.28

1.55

2.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

113

1.56

1.55

1.0

0.86

2.45

u/ml

0.77

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

214

909

1.18

1.52

3.6

4.2

132.58

1202.69

u/ml

1.77

203

830

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.90

1.46

1.1

1.0

—

(3033799) Differential panel - Peritoneal fluid

127

1.50

1.46

2.1

1.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.98

1.45

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

438

1967

1.12

1.45

3.1

4.2

6274.73

1592.39

u/ml

0.37

374

1717

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.39

1.45

1.0

0.10

0.11

u/ml

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.59

1.45

1.4

1.0

2.71

1.87

mmol/24h

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.70

1.44

1.0

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.70

1.44

2.0

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

193

819

1.18

1.41

1.1

1.2

4.02

3.00

u/ml

0.15

318

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.58

1.40

6.1

3.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.70

1.37

3.8

2.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.26

1.34

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.73

1.33

3.2

1.6

0.80

0.64

u/field

0.27

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.51

1.32

1.3

1.4

220.10

305.94

nmol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

729

3377

1.09

1.32

1.6

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

139

1.45

1.30

2.6

1.5

3426.18

5242.88

e6/l

0.34

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.55

1.30

1.6

1.2

23.91

28.55

g/l

0.57

(3006567) Chloride [Moles/time] in 24 hour Urine

3.14

1.30

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

119

1.48

1.27

1.1

—

(3044007) Cell count panel - Peritoneal fluid

132

1.45

1.25

2.2

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

779

4208

0.93

1.24

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.01

1.22

2.0

1.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.67

1.21

1.1

40.61

49.28

mg/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

168

717

1.18

1.20

1.6

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

364

0.76

1.20

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

268

1.29

1.18

2.6

2.3

169.65

105.77

ng/l

0.79

180

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

403

1.23

1.16

5.5

7.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

567

0.81

1.12

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.15

1.10

1.1

1.3

1.57

1.47

—

(3016031) Almond IgE Ab [Units/volume] in Serum

107

1.46

1.08

1.0

0.30

1.37

u/ml

2.77

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

330

1492

1.11

1.05

1.6

7.68

7.28

mmol/l

3.08

317

1431

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.96

1.03

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.01

1.03

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.51

0.99

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.07

0.99

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

159

918

0.87

0.96

1.6

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.32

0.95

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.32

0.95

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

132

574

1.16

0.83

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

114

0.66

0.79

1.0

165.73

163.73

g/l

0.20

114

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

219

990

1.11

0.77

1.8

2.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.09

0.74

1.2

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.76

0.71

15.7

7.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.59

0.71

1.2

1.3

6.50

18.65

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.47

0.68

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

249

1.21

0.68

1.1

1.0

20.12

19.70

mmol/l

0.50

244

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.67

0.67

1.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.79

0.64

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.64

1.3

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

121

685

0.89

0.62

1.2

1.3

1.52

1.54

g/l

0.40

121

685

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.77

0.59

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.58

0.59

2.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.62

0.59

2.2

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.61

0.58

1.1

1.0

7.99

8.84

mmol/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

143

648

1.11

0.54

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

127

0.75

0.54

3.6

3.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.42

0.53

3.4

3.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

112

502

1.12

0.52

1.3

1.4

—

(40758292) HTLV I+II Ab panel - Serum

156

1.22

0.51

1.2

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.45

0.51

1.7

1.3

298.38

310.89

umol/24h

0.11

(40760410) HLA-B [Type] by High resolution

1.60

0.50

1.0

—

(40760409) HLA-A [Type] by High resolution

1.60

0.50

1.0

—

(3013762) Body weight Measured

1.47

0.50

1.1

1.2

—

(46236302) HLA-C [Type] by High resolution typing

1.53

0.49

1.0

—

(3013862) HLA-DP [Type]

1.53

0.49

1.0

—

(40763590) HLA-DQ beta [Type]

1.53

0.49

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.69

0.48

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.38

0.43

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.29

0.43

1.2

1.1

28.17

20.33

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

119

1.22

0.41

2.4

2.7

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.48

0.40

1.0

37.18

35.62

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.48

0.40

1.0

18.84

21.92

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

106

1.23

0.39

1.1

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

139

1.19

0.38

1.1

2.2

1.23

3.90

ug/l

0.89

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.51

0.37

1.2

1.1

—

(3032641) Amino acids panel - Urine

1.41

0.33

1.4

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.35

0.32

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

324

1.10

0.29

1.7

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.26

0.28

1.3

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

103

481

1.08

0.27

1.3

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.21

0.25

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

106

567

0.94

0.23

2.8

3.2

—

(3004959) Base excess in Arterial cord blood by calculation

239

1.09

0.21

1.0

-1.16

-2.12

mmol/l

0.47

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

240

1.09

0.20

1.0

6.90

7.32

kpa

1.02

213

(3006598) pH of Arterial cord blood

240

1.09

0.20

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

236

1.09

0.18

1.0

3.72

3.49

kpa

0.21

207

(3039443) Prostate specific Ag panel - Serum or Plasma

271

1404

0.97

0.18

1.6

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

1.23

0.18

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

1.22

0.16

7.1

7.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

123

1.10

0.14

5.9

8.6

—

(3034614) HLA Ag [Interpretation]

1.20

0.10

1.2

1.1

—

(3008607) Semen analysis panel

131

1.07

0.09

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

133

652

1.02

0.08

1.3

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.11

0.06

1.1

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

190

967

0.99

0.05

1.4

1.3

29.20

33.88

nmol/l

1.62

168

909

(3025130) Human papilloma virus identified in Specimen

319

1587

1.01

0.04

1.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

467

2359

0.99

0.04

1.3

4.13

ug/l

0.00

438

2202

(3022670) pH of Venous cord blood

0.93

0.03

1.1

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

121

1.04

0.02

6.2

2.8

7.02

4.52

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

108

1.02

0.00

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: NEURODIS – Neurological diseases, wide definition

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Neurological diseases, wide definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints